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Abstract 
Fatigue can accumulate sufficiently to limit muscular force production during repeated, 
forceful muscle contractions, including those that occur in the occupational, clinical and athletic 
settings. Fatigue during such efforts is likely to result from disturbances to multiple processes in 
the nervous system and muscle. However, previous research examining the mechanisms 
underpinning fatigue have typically required subjects to perform low-level constant-force 
contractions or to repeat maximal efforts in a single set format. Such tasks do not translate well to 
occupational, daily living or athletic situations where high-intensity, yet submaximal, repeated 
efforts may be performed in work bouts (or sets) with brief rest periods for recovery. Therefore, 
the overall aim of the present research was to investigate the neuromuscular mechanisms 
contributing to force loss after repeated, high-intensity muscular efforts with longer (90 s) periods 
of rest separating repetitions into sets of contractions. 
In Experiment 1, 16 resistance trained men performed 6 sets of unilateral isometric plantar 
flexor contractions of the right leg (3 s contraction/2 s rest) reaching a target level of 85% maximal 
voluntary contraction (MVC). Sets were separated by a 90-s inter-set rest and completed to failure 
(i.e. <85% MVC) both with and without caffeine ingestion (3 mg·kg-1) on two separate days. 
Caffeine was used to help identify potential physiological changes that might be responsible for 
the loss of force during high-intensity muscular efforts. Maximal isometric plantar flexor strength, 
efferent neural drive, corticospinal excitability (motor evoked potential amplitude normalised to 
M-wave amplitude; MEP/M) and intracortical inhibition (cortical silent period) were assessed 
before (PRE) and immediately (POST), 10 min (POST-10) and 20 min (POST-20) after the 
exercise using isokinetic dynamometry, muscle electromyography (EMG normalised to M-wave 
amplitude; EMG/M) and transcranial magnetic stimulation during both the non-caffeine and 
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caffeine conditions. In Experiment 2, tetanic stimulations (20 Hz, 80 Hz and variable frequency 
trains [VFT; 20-Hz trains commencing with 100-Hz ‘doublet’]) were imposed to quantify 
excitation-contraction coupling (E-C coupling) efficiency. Additionally, neuromuscular electrical 
stimulation was imposed during ongoing Achilles tendon vibration (VIB+STIM; 115 Hz vibration) 
in order to estimate persistent inward current (PIC)-mediated facilitation of the motor neurone 
(MN) pool before and after the same exercise intervention in 17 resistance trained men. During 
the VIB+STIM test, MN (PIC) facilitation was quantified as the mean torque at two time points 
throughout the test; during vibration (Tvib) and 500 ms after vibration was ceased (Tsust). Results 
are reported relative to baseline.  
In Experiment 1, a significant reduction in maximum voluntary isometric plantar flexion 
torque (12.2%; p < 0.001) was observed post-exercise, which did not recover by POST-20. 
Significant reductions in triceps surae EMG/M (-6%; p = 0.024) and MEP/M amplitude (9%; p = 
0.01) were found post-exercise but recovered by POST-10. Cortical silent period (an indicator of 
GABAB-mediated intracortical inhibition) was reduced (-4%; p = 0.016) post-exercise and did not 
recover by POST-20. In Experiment 2, temporal changes in torque were similar to Experiment 1. 
Significant reductions in the evoked torque response from 20 Hz (p < 0.001), 80 Hz (p < 0.001) 
and VFT (p < 0.001) stimulations were observed at POST and did not recover by POST-20, 
however no changes in 20:80 and 20:VFT ratios were observed. Finally, significant reductions in 
both Tvib (-13%; p = 0.035) and Tsust (-25%; p = 0.035) were found post-exercise but recovered by 
POST-10. The ingestion of caffeine allowed for a greater overall torque production and neural 
drive (EMG/M) but the lack of condition  time interaction effect indicated that it did not clearly 
affect the time course of fatigue or recovery. Further, no detectable effects were observed compared 
to the non-caffeine condition in corticospinal excitability, MN excitability or E-C coupling, as 
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shown by the negligible changes in MEP/M amplitude, PIC facilitation, and torque during 20-Hz, 
80-Hz and VFT stimulations.  
These data suggest that corticospinal tract efficiency and PIC-mediated facilitation of the 
MN pool can be compromised and are likely to account in part for the force loss immediately 
following an acute bout of repeated, high-intensity muscular efforts performed in sets (with 90 s 
rest). However, changes in E-C coupling efficiency (i.e. ‘peripheral fatigue) are likely to explain 
the ongoing, prolonged loss of force, at least to 20 min post-exercise. Therefore, it is likely that 
both changes in the nervous system as well as the muscle contribute to the loss of force following 
repeated, high-intensity muscular efforts. 
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Introduction and Overview 
 
Humans commonly perform repeated high-intensity, yet submaximal, muscular efforts. 
This is done in occupational settings where repetitive lifting (e.g. moving objects, shovelling, 
etc.) is regularly performed, clinical settings where individuals with functional limitations are 
required to work at a higher proportion of their maximum (compared to non-limited 
individuals) to complete activities of daily living, and athletic pursuits where repeated high-
intensity efforts are required for successful performance. Such efforts are also common to 
strength training, which is traditionally used as a tool to improve strength, power and muscle 
mass (Stone, Stone, & Sands, 2007) in order to improve sporting/athletic performance or to 
prevent skeletal muscle loss, reduce morbidity and mortality, and improve physical function in 
older and clinical populations (Liu & Latham, 2009; Warburton, Nicol, & Bredin, 2006). 
However, the ability to perform repeated high-intensity muscular efforts is limited by the 
accumulation of fatigue, where the work output required to continue the activity can no longer 
be sustained. Thus, there is a need to understand the factors influencing, and mechanisms 
underpinning, fatigue during such tasks in order that strategies might be developed to mitigate 
against it and, in turn, improve exercise (physical work) performance. 
Muscle fatigue can be defined as any exercise-induced reduction in the ability to 
produce force or power with a muscle or muscle group and can result from changes in function 
at multiple sites along the neuromuscular pathway (Bigland‐Ritchie & Woods, 1984; Gandevia, 
2001; Taylor & Gandevia, 2008). From a nomenclature perspective, fatigue resulting from 
processes at or distal to the neuromuscular junction has been commonly referred to as 
“peripheral fatigue”, whilst fatigue that manifests above the neuromuscular junction (i.e. brain, 
spinal cord and motor neurones) has often been referred to as “central fatigue” (Taylor & 
Gandevia, 2008). It is likely that both peripheral and central aspects of fatigue play a role in 
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the response to repeated high-intensity muscular efforts. However, previous research 
examining the mechanisms underpinning fatigue have typically focused on examinations of a 
relatively small number of changes within the neuromuscular pathway, which precludes the 
development of a clear picture of changes throughout the whole neuromuscular system. 
Furthermore, the majority of research investigating the effects of fatigue on muscular 
performance has typically imposed either sustained or repeated maximal efforts for time or 
predefined level of maximal force output, or sustained low-intensity submaximal voluntary 
contractions (Hoffman, Oya, Carroll, & Cresswell, 2009; Taylor, Butler, Allen, & Gandevia, 
1996; Taylor & Gandevia, 2008). However, these types of tasks rarely apply in occupational, 
daily living or athletic situations, and it is not known how much understanding can be gained 
from the use of these paradigms. Furthermore, bouts of work are often performed with 
intervening rest periods in most occupational, daily living or athletic tasks, and is a hallmark 
of strength training practice (Bompa & Haff, 2009). However, these are rarely performed in 
research studies. Therefore, it is possible that the physiological changes leading to fatigue in 
the work bouts with different work:rest ratios used in previous studies are different, or at least 
of different relative importance, to those leading to fatigue in the repeated high-intensity efforts 
performed in many occupational, clinical and athletic environments. Finally, a significant part 
of our understanding comes from ex vivo work in single fibre preparations (Edman & Lou, 
1990; Lamb, 2002). While such work has contributed significantly to our understanding of the 
fatigue process, at least at the peripheral level, consideration of the test protocols is needed in 
order to estimate the relevance to organism-level changes. 
In the following review of literature, the potential for central and peripheral 
mechanisms to influence fatigue-induced force loss will be considered with a view to 
developing specific testable hypotheses for future research examining the fatigue responses to 
the repeated high-intensity muscular efforts that are performed as work bouts with short inter-
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bout rest periods in many occupational, clinical and athletic environments, and especially in 
strength training. 
 
1.1 Peripheral factors influencing fatigue 
  
1.1.1 Impairment of the excitation-contraction (E-C) coupling process 
Peripheral changes contribute to the majority of fatigue induced by an acute bout 
maximal or high-intensity but submaximal exercise (Nordlund, Thorstensson, & Cresswell, 
2004; Schillings, Hoefsloot, Stegeman, & Zwarts, 2003) and can be attributed to multiple 
mechanisms. Metabolic changes within the muscle are an important mechanism. These 
metabolic changes include reductions in ATP synthesis as well as accumulation of hydrogen 
ions (H+), leading to a decrease in intracellular pH (i.e. acidosis), inorganic phosphate (Pi), 
which is hydrolysed from creatine phosphate in the resynthesis of ATP, and extracellular K+. 
These changes in ionic concentrations in the cell reduce sarcolemmal excitability and thus force 
development (McKenna, Bangsbo, & Renaud, 2008). Additionally, ADP accumulation 
adjacent to the contractile proteins is thought to negatively impact contractile function, 
although probably to a lesser extent other than metabolic changes (Allen, 2009; Allen, Lamb, 
& Westerblad, 2008; Debold, 2016). 
At sub-physiological temperatures (10-15oC), elevated levels of Pi and H+ to 
physiological fatiguing levels are known to decrease maximal isometric force by >50% 
(Debold, 2016; Nosek, Fender, & Godt, 1987). However, recent work has demonstrated that Pi 
and H+ accumulation reduces isometric force by only 5-20% (Debold, Dave, & Fitts, 2004) and 
10% (Knuth, Dave, Peters, & Fitts, 2006; Pate, Bhimani, Franks-Skiba, & Cooke, 1995), 
respectively, at near-physiological temperatures (30oC) for the same increase in Pi and H+ seen 
during the low temperature conditions. However, when both metabolites are elevated 
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simultaneously, as is the case during exercise-related fatigue in vivo, their individual effects are 
additive, and have been shown to induce a greater level of fatigue (Debold, 2016; Nelson, 
Debold, & Fitts, 2014). Nonetheless, larger force losses are typically observed in single fibre 
studies when the same level of metabolite accumulation is evoked as in fatiguing exercise 
(Vedsted, Larsen, Madsen, & Sjøgaard, 2003). Therefore, it can be concluded that factors 
additional to the biochemical changes must contribute to the total force reduction in muscles 
during fatigue. 
A second mechanism affecting fatigue at the peripheral level is a change in intracellular 
calcium handling, resulting from a reduction in sarcoplasmic reticulum calcium (Ca2+) release 
as well as a reduced sensitivity of the contractile proteins to Ca2+, which ultimately impairs the 
excitation-contraction (E-C) coupling process (Debold, 2016). Inside the muscle, increases in 
Ca2+ concentration mandate the binding of myosin to actin, and thus the development of 
muscular force, via the movement of tropomyosin which allows myosin to bind strongly to 
actin (Debold, 2016). Therefore, the efficiency of Ca2+ transport plays a key role in muscular 
contraction (Maffiuletti et al., 2016; Nielsen, 2009). It is believed that accumulation of 
metabolic by-products and compromised release of Ca2+ from the sarcoplasmic reticulum (SR) 
act synergistically to cause much of the loss in muscle function during fatigue (Debold, 2016).  
In addition to reduced Ca2+ release, elevated levels of metabolic by-products have also 
been shown to decrease the sensitivity of the myofilaments (actin and myosin) to Ca2+. The 
reduced Ca2+ sensitivity causes a rightward shift in the force-calcium relation that exacerbates 
the effects of reduced Ca2+ release such that the level of Ca2+ required to elicit 50% of the 
maximal isometric force is increased by 2-fold in the presence of a fatiguing level of Pi in vitro. 
Additionally, the level of Ca2+ needed to cause actomyosin interaction is even more pronounced 
near physiological temperatures. Therefore, elevated levels of metabolic by-products can cause 
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both a decrease in the release of Ca2+ as well as a reduction in the muscle’s sensitivity to Ca2+ 
(Debold, 2016). 
 As changes in the E-C coupling process contribute to the loss of force during fatigue 
(Allen, Westerblad, Lee, & Lännergren, 1992; Pasquet, Carpentier, Duchateau, & Hainaut, 
2000), further research is required in order to quantify the change in E-C coupling efficiency 
during repeated high-intensity muscular contractions. This might be assessed in vivo by 
comparing the peak torque produced during high- (e.g. 80 - 100 Hz) vs. low- (e.g. 20 Hz) 
frequency neuromuscular electrical stimulation, to quantify ‘low-frequency fatigue’ (LFF) 
(Edwards, Hill, Jones, & Merton, 1977; Jones, 1996; Martin, Millet, Martin, Deley, & Lattier, 
2004). LFF is characterised by a proportionately greater loss of force in response to low- versus 
high-frequency muscle stimulation (Keeton & Binder-Macleod, 2006). It is understood that the 
greater loss of force in the low frequency stimulation is caused by an elevated Ca2+ 
concentration in the triadic junction (see Figure 1.1 below). This is attributable to impairment 
in the interaction between voltage-sensitive dihydropyridine receptors and calcium-release 
ryanodine receptors (RyR) (Balog, 2010; Lamb, 2000). One factor that might disrupt the 
interaction between receptors is an increased sarcoplasmic Ca2+ concentration causing a 
reduction in calcium release by the RyR during muscle contraction (Allen, 2004; Balog, 2010). 
In contrast, during the high frequency stimulation, force loss is typically less due to the 
supraphysiological stimulation rate which allows more Ca2+ to be released from the 
sarcoplasmic reticulum into the myoplasm (Edwards et al., 1977; Moss, Lynch, & Fitzsimons, 
2017). However, if force loss does occur during high frequency stimulation, then it is possible 
that other processes such as Ca2+ sensitivity (partly caused by increased H+ or Pi) or a loss of 
force transmission through the series elastic component of the muscle-tendon unit might be 
factors (Debold, 2016; Mademli & Arampatzis, 2005). In addition, LFF and increased 
sarcoplasmic calcium concentration are most notably observed during eccentric contractions 
6 
 
or isometric exercises at a long muscle lengths (Jones, 1996; Keeton & Binder-Macleod, 2006; 
Martin et al., 2004), which suggests that E-C coupling efficiency may be affected differently 
depending on the type of exercise being performed. Therefore, assessing reductions in this ratio 
(20:80 ratio) might provide valuable insight into the mechanisms underpinning E-C coupling 
efficiency (Jones, 1996; MacIntosh & Rassier, 2002; Martin et al., 2004), and the use of LFF 
tests might provide valuable insight into the mechanisms of fatigue during repeated high-
intensity exercise. 
  
Figure 1.1. Schematic diagram of calcium release in skeletal muscle. The depolarisation of an action 
potential is detected by the voltage sensitive dihydropyridine receptors in the t system, which directly 
controls the opening and closure of the Ca2+ release channels (RyR) in the adjacent SR without the need 
for influx of extracellular Ca2+ (modified from Lamb, 2000). Increased sarcoplasmic Ca2+ concentration 
is believed to disrupt the interaction between receptors (Balog, 2010). 
 
1.1.2 Muscle “catch-like” properties 
The catch-like property of skeletal muscle refers to the force augmentation that occurs 
when two action potentials (i.e. a doublet) arrive at the muscle with a very short (e.g. 10 ms) 
delay at the onset of a voluntary contraction (Binder‐Macleod & Kesar, 2005; Burke, Rudomin, 
& Zajac, 1970; Garland & Griffin, 1999). This high-frequency burst at the motor neurone (MN) 
t	system
Voltage	sensor	
(DHPR)
Ca2+ release	channel	(RyR1)
Ca2+
SR
Contractile	proteins
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serves to enhance muscle force without the need to increase mean firing frequency/discharge 
rate (Binder‐Macleod & Kesar, 2005). It is believed that the catch-like property can be evoked 
by the nervous system during volitional movements to compensate for the loss of muscle force 
that accompanies fatigue (Binder‐Macleod & Kesar, 2005; Griffin, Garland, & Ivanova, 1998). 
Two primary mechanisms have been proposed to explain the force enhancing effects: 1) 
increased sarcoplasmic reticulum calcium release via the RyR receptor (Cheng, Place, Bruton, 
Holmberg, & Westerblad, 2013) and 2) increased stiffness of the series elastic elements of 
muscle (Binder-Macleod & Barrish, 1992; Burke, Rudomin, & Zajac, 1976; Parmiggiani & 
Stein, 1981). The latter mechanism is thought to work by the rapid shortening of contractile 
elements stretching the muscle’s series elastic elements thus increasing the stiffness of the 
system and in turn force transmission velocity (Binder‐Macleod & Kesar, 2005; Parmiggiani 
& Stein, 1981). Interestingly, the force enhancing effects of the high-frequency burst at 
stimulation onset are more pronounced during low-frequency fatigue (Bentley & Lehman, 
2005). This is suggestive that that the catch-like property might be an essential mechanism for 
counteracting the loss of force during fatigue by upregulating sarcoplasmic reticulum Ca2+ 
release (Bentley & Lehman, 2005; Binder-Macleod & Russ, 1999; Cheng et al., 2013) and, in 
turn, increasing the number of binding sites for cross-bridge formation (Bakker, Cully, 
Wingate, Barclay, & Launikonis, 2017; Cheng et al., 2013). 
In order to gain a greater understanding of the catch-like effect on muscle contractile 
force and fatigue the use of muscle or nerve stimulation can be used by applying a brief, high-
frequency burst of two to four electrical pulses followed by a constant low-frequency 
stimulation train to a muscle or nerve (i.e. a variable frequency train; VFT) (Binder‐Macleod 
& Kesar, 2005; Burke et al., 1970). It is believed the initial high-frequency burst at the 
beginning of the train increases the myofibrillar affinity for Ca2+, resulting in an increased rate 
of force development and peak contractile torque when compared to a constant-frequency train 
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of equivalent intensity and frequency (Bakker et al., 2017; Cheng et al., 2013). Therefore, the 
use of a VFT, along with measurements of the 20:80 Hz ratio, should provide valuable 
information with regard to calcium handling during repeated high-intensity exercise. 
 
1.2 Central factors influencing fatigue 
 
Whilst many of the changes influencing muscle function during fatiguing exercise 
occur peripherally, at least part of this fatigue occurs because the central nervous system loses 
its ability to fully activate the muscles (called ‘central drive’ failure) (Gandevia, 2001; Goodall, 
Charlton, Howatson, & Thomas, 2015). Determining the mechanisms that underpin this loss of 
central drive is essential in order to develop strategies to reduce fatigue and thus improve 
exercise performance. 
In a voluntary contraction, an excitatory signal is initiated in the motor cortex that 
descends largely via the corticospinal tract to the MN. If the net excitatory synaptic input, from 
temporal and spatial summation of excitatory postsynaptic potentials, is of sufficient strength 
to depolarise the MN to its spiking threshold then an action potential is generated at the axon 
initial segment of the MN. The resulting MN action potential(s) then propagates along the axon 
to the neuromuscular junction and triggers postsynaptic action potentials in the membranes 
(sarcolemma) of muscle fibres (Gandevia, 2001; Heckman & Enoka, 2012a), resulting in 
calcium release from the sarcoplasmic reticulum and actomyosin interaction (i.e. E-C coupling) 
(Balog, 2010). The force produced in the contraction is dependent on both the number of motor 
units recruited as well as their discharge rate (Gandevia, 2001; Henneman, 1985). Therefore 
factors reducing the descending drive to the muscle should significantly and negatively affect 
E-C coupling and in turn muscular force production. 
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1.2.1 Supra-spinal mechanisms 
Activity within the motor cortex determines the level descending drive (i.e. to the 
muscle), therefore alterations in supra-spinal drive can noticeably affect muscular force 
production (Gandevia, 2001). A reduction in cortical outflow has been shown to result in a loss 
of muscle force due to the inability of the descending supra-spinal drive to maximally activate 
the muscle’s motor neurone pool (Gandevia, 2001). This could result from alterations in the 
net excitability of the motor cortex in response to peripheral sensory feedback from group 
III/IV nociceptive afferents, which could activate intracortical inhibitory circuits and reduce 
motor cortical output (Nijs et al., 2012; Taylor, Butler, & Gandevia, 2000; Taylor & Gandevia, 
2008), and thus muscle force during fatigue. ‘Supra-spinal fatigue’ has been shown to 
contribute up to approximately one-quarter of the force loss during prolonged (2-min) maximal 
voluntary contractions (MVCs) (Taylor & Gandevia, 2008). Therefore force loss appears to be 
attributable in part to a reduction in motor cortical outflow (Gandevia, Allen, Butler, & Taylor, 
1996; Gandevia, Petersen, Butler, & Taylor, 1999). However, it is not known whether such 
changes contribute substantially to muscle work during strength training, or occupational and 
daily tasks that require the performance of high intensity, yet submaximal, force production 
with intermittent periods of rest. 
 
1.2.2 Spinal Mechanisms 
The spinal circuitry is a complex network of sensory neurones, inter-neurones and 
MNs. In addition to supra-spinal fatigue, the responsiveness of spinal α-motor neurones (MNs) 
to descending input also declines profoundly with fatigue during maximal muscular 
contractions (McNeil, Giesebrecht, Gandevia, & Taylor, 2011; Taylor, Butler, et al., 2000). 
Whilst it is sometimes assumed that MNs passively convey cortical drive to the muscles, 
intrinsic MN properties and sensory feedback to the spinal cord can alter descending drive by 
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inhibiting or facilitating MNs (Nielsen, 2004). Thus, the reduction in neural drive and muscular 
force during fatigue could potentially result from MN inhibition and/or disfacilitation at the 
spinal level (Gruet et al., 2013; McNeil, Martin, Gandevia, & Taylor, 2009). In fact, at high 
discharge rates such as those seen in strong contractions, MN output may be more limited by 
the properties of the MN pool rather than the motor cortex (Martin, Gandevia, & Taylor, 2006; 
McNeil et al., 2009). For example, force augmentation resulting from both stimulation of the 
motor cortex (using transcranial stimulation) and the descending corticospinal pathways (using 
cervicomedullary stimulation) during maximal isometric contractions were simultaneously 
reduced with increasing levels of muscular contraction strength (Martin et al., 2006), indicating 
that motor cortical output was not a limiting factor for force production at high levels of 
contraction force and that effects below the level of the motor cortex (likely at the MN) were 
responsible for the reduction in evoked output (i.e. increased central/neural drive). Therefore, 
it would be of interest to determine whether changes in intrinsic MN properties and sensory 
feedback also play a role in the fatigue response during repeated high-intensity yet submaximal 
contractions. 
Although strong evidence indicates that a portion of the fatigue resulting from intense 
muscular contractions such as those performed during strength training and other intense 
exercise activities results from a reduction in MN excitability (McNeil et al., 2009; Taylor, 
Butler, et al., 2000), no evidence exists for the specific site at which these changes occur. One 
potential factor influencing MN excitability is a change in somatosensory feedback, which 
might affect pre- or post-synaptic sites. Butler, Taylor, and Gandevia (2003) investigated 
whether group III and IV afferents contributed to the decline in discharge rate by performing 
elbow flexor MVCs during ischaemic muscle conditions. They observed a decrease in MN 
excitability, however cervicomedullary evoked potential (CMEP) amplitudes did not differ 
between ischaemic and control conditions, indicating that group III and IV afferent activity did 
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not notably influence the force decline. McNeil, Giesebrecht, Khan, Gandevia, and Taylor 
(2011) later examined the effect of the withdrawal of excitatory input to MNs from muscle 
spindles during prolonged (2 min) MVCs by using tendon vibration to mechanically increase 
muscle spindle discharge rates and increase Ia-excitatory input to the MN pool. They observed 
an increase in the muscle torque evoked by tendon vibration during sustained MVCs, however 
the increase in spindle activity did not affect the conditioned CMEP size (an indicator of MN 
excitability). The authors concluded that although muscle spindle afferents contributed to MN 
pool excitability, changes in the intrinsic MN properties caused by repetitive discharge were 
most probably responsible for the reduction in MN excitability during fatigue. There is 
compelling evidence that sensory afferents such as stretch-sensitive muscle spindles (Ia and 
II), tension-sensitive golgi tendon organs (Ib), pressure-sensitive joint receptors (II), and pain- 
and stretch-sensitive free-nerve endings (II, III and IV) are able to alter the synaptic input to 
the MN pool via inhibitory and excitatory inputs. In fact, sensory inputs, especially from group 
Ia afferents, can strongly affect MN facilitatory/amplification mechanisms, which could play a 
larger role during fatigue (Gandevia, 1998; Powers & Binder, 2001; Taylor, Amann, Duchateau, 
Meeusen, & Rice, 2016). Several lines of evidence support this conclusion (Gandevia, 1998; 
Khan, Giesebrecht, Gandevia, & Taylor, 2012) and point to two potential mechanisms 
underpinning the loss in MN excitability during fatigue. The first relates to changes in 
neuromodulatory effects at the somato-dendritic end of the MN (Perrier, Rasmussen, 
Christensen, & Petersen, 2013). It has been shown that motor unit discharge rates slow during 
fatiguing voluntary contractions as the contraction and relaxation of muscle fibres slow 
(Gandevia, 1998; Taylor, Butler, et al., 2000). Although the mechanism by which the slowing 
of MN discharge is unclear, a reduction in persistent inward current (PIC) formation could 
possibly be a factor that has not yet been tested (Binder, 2003; Heckman, Gorassini, & Bennett, 
2005). A PIC is a depolarising current generated by voltage-sensitive channels in the MN that 
12 
 
tend to remain active as long as the membrane potential remains above activation threshold 
(Heckman et al., 2005). When activated, PICs amplify and prolong synaptic input (Hultborn, 
Denton, Wienecke, & Nielsen, 2003) and thus change the input-output relationship at the 
synapse to produce a sustained depolarisation, particularly in low-threshold MNs (Heckman, 
Johnson, Mottram, & Schuster, 2008; Lee & Heckman, 1996). This amplification allows the 
MN to fire more rapidly to produce maximal levels of muscular force (Hultborn et al., 2003). 
PICs are primarily located at the dendrites of the MN and are commonly generated by 
two types of voltage-sensitive channels: L-type Ca2+ channels and persistent Na+ channels 
(Bennett, Hultborn, Fedirchuk, & Gorassini, 1998; Carlin, Jones, Jiang, Jordan, & Brownstone, 
2000; Hounsgaard & Kiehn, 1993; Lee & Heckman, 1999). These channels are highly receptive 
to monoaminergic drive, in particular serotonin (5-HT) and noradrenaline in the spinal cord 
(Heckman & Enoka, 2012a; Heckman, Lee, & Brownstone, 2003; Perrier et al., 2013). Both of 
these neurotransmitters have potent effects on MNs by hyperpolarising the activation voltage 
for PICs (Heckman & Enoka, 2012a) and therefore increasing the likelihood that a MN will 
fire an action potential. Monoaminergic drive is essential for the generation of PICs, as shown 
using in vivo experiments on decerebrate cats where PIC generation was found to disappear 
after spinalisation and reappear after intravenous injection of a 5-HT precursor (5-
hydroxytryptophan) (Crone, Hultborn, Kiehn, Mazieres, & Wigström, 1988; Hounsgaard, 
Hultborn, Jespersen, & Kiehn, 1988). The importance of this is such that PICs can be 
modulated across different behavioural states by changing the monoaminergic drive to the MN 
dendrites and thus changing the excitability of the MN (Heckman et al., 2003), which should 
allow the generation of very high forces despite modest input levels (Binder, 2003). 
 Sustained force generation is likely to depend on PICs (Heckman et al., 2003). In the 
absence of neuromodulatory input, ionotropic input alone (i.e. Na+/K+ flux) is not sufficient to 
drive high threshold (fast-twitch) motor units at their maximum force outputs (Lee, Kuo, Jiang, 
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& Heckman, 2003). In the absence of monoaminergic drive, and thus absence of PIC 
amplification (Perrier & Delgado-Lezama, 2005), force generation above 50% of voluntary 
maximum would not be possible (Heckman et al., 2005). Therefore, PIC behaviour in MNs is 
essential for force production in both maximal and submaximal contractions. During fatigue, 
however, PICs are likely to be affected in two ways: 1) at the somato-dendritic site due to a 
reduction in serotonergic and/or noradrenergic drive, which could be caused by a reduction in 
output from nerves arising in the brainstem (locus coeruleus or raphe nucleus output) 
(Heckman et al., 2003), or 2) a reduction in stimulatory afferent feedback, especially reductions 
in feedback from Ia afferents due to reductions in muscle spindle discharge rates (Macefield, 
Hagbarth, Gorman, Gandevia, & Burke, 1991). Regardless of the mechanism, a reduction in 
PIC amplitude is likely to negatively affect MN excitability and thus there would be a 
requirement for an upregulation of motor cortical output in order to maintain the same force 
output (McNeil et al., 2009), ultimately leading to a reduction in voluntary force and a higher 
level of perceived effort (Taylor, Butler, et al., 2000). Nonetheless, it is not known whether 
there is a reduction in PIC amplitude during repeated high-intensity, voluntary muscular 
contractions, such as those performed during strength training or other forms of high-intensity 
exercise. It is therefore also not known whether interventions targeting the activation of PICs 
can alleviate fatigue symptoms. 
A second mechanism that might influence the loss of MN excitability during fatigue is 
a functional change at the initial segment of the axon hillock (Khan et al., 2012). This may 
result from the spillover of serotonin (5-HT) from the somato-dendritic compartment to 
inhibitory 5HT1A receptor sites at the axon initial segment during prolonged or high magnitude 
muscle activation and in turn inhibit the generation of action potentials. (Cotel, Exley, Cragg, 
& Perrier, 2013; D’Amico et al., 2015). While there is limited direct evidence to support the 
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hypothesis that serotonin spillover contributes to fatigue, the possibility exists that this 
mechanism plays a role. 
 
1.2.3 Limitations to previous research examining neural (central) drive after muscle 
fatigue 
One of the limitations of previous research examining the effects of supra-spinal drive 
and MN excitability in fatigue is the lack of applicability to occupational, clinical and athletic 
settings. Previous studies have tended to utilise either continual submaximal or maximal efforts 
where little to no rest is afforded throughout the intervention (McNeil et al., 2009; Taylor et al., 
1996; Yoon, Schlinder Delap, Griffith, & Hunter, 2007), or maximal intermittent efforts to a 
predefined percentage of maximum capacity (Kalmar, Del Balso, & Cafarelli, 2006). Whilst 
these strategies are effective for determining fatigue-induced changes in central drive, they do 
lack in their applicability to the tasks encountered in the occupational, clinical and athletic 
settings. For instance, in practice, work bouts typically occur at a high yet submaximal intensity 
relative to maximum capacity. In addition, these work bouts are usually accompanied by rest 
interspaced between efforts. An example of this might be strength training where intensities 
typically range between 60-90% maximum capacity and are accompanied by small periods of 
rest between repetitions and sets of an exercise. Therefore, an intervention that accounts for 
intensity, contraction duration and the recovery between efforts might help to better explain the 
effect of central and peripheral factors on fatigue during occupational, clinical and athletic 
settings. 
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1.3 Measuring central factors influencing fatigue 
 
There are a variety of methods available to assess the neurophysiological function of 
the corticospinal-motoneuronal pathway and its effect on muscular force development. These 
methods include electrical or magnetic stimulation of the motor cortex, corticospinal tract and 
peripheral nerves (see Capaday (1997); McNeil, Butler, Taylor, and Gandevia (2013); Petersen, 
Pyndt, and Nielsen (2003); Taylor and Gandevia (2004) for reviews). The techniques used in 
the present thesis are explained below. 
 
1.3.1 Corticospinal Excitability and Transcranial Magnetic Stimulation 
In order to test whether a loss in corticospinal excitability occurs after performing 
repeated high-intensity muscle contractions, electromyography (EMG) and transcranial 
magnetic stimulation (TMS) can be used by applying a single short-lasting supra-threshold 
magnetic pulse over the motor cortex to produce a short-latency excitatory response in muscle 
known as a motor-evoked potential (MEP) (Di Lazzaro, Rothwell, & Capogna, 2017; Petersen 
et al., 2003). MEPs can be recorded from both upper and lower-limb muscles (Rothwell, 
Thompson, Day, Boyd, & Marsden, 1991) and are considered to be a reliable method for 
assessing the function of the corticospinal pathway. As the MEP is influenced by the 
excitability of the corticospinal-motoneuronal pathway, the size (i.e. amplitude or area) of the 
MEP is often used as an indicator of corticospinal excitability (Petersen et al., 2003; Rothwell, 
1997). 
 A TMS pulse can be delivered at rest or during muscle contraction, both of which can 
be used to assess different aspects of the corticospinal-motoneuronal pathway (McNeil et al., 
2013). At rest, MEPs evoked from TMS provide information regarding the balance between 
excitation and inhibition in the corticospinal-motoneuronal pathway (Chen, 2004). However, 
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by performing the TMS pulse during a voluntary contraction, the amplitude of the MEP is 
significantly increased when compared to at rest (Nielsen & Petersen, 1995). This increase in 
MEP amplitude is believed to result from a larger fraction of MNs being excited by the 
descending corticospinal volley because MN excitability is increased as the synaptic 
facilitation of MNs brings some MNs closer to their firing threshold (Di Lazzaro et al., 2001; 
Kaneko, Kawai, Fuchigami, Shiraishi, & Ito, 1996). Therefore, MEPs evoked during a 
voluntary contraction can provide additional information on facilitatory pathways throughout 
the human motor system. 
 An added benefit of measuring MEPs during voluntary contractions is that a second 
evoked response can be elicited that provides information relating to specific aspects of intra-
cortical inhibition. The evoked MEP from TMS during voluntary contraction elicits a brief 
period of near silence in the ongoing EMG, known as the cortical silent period (cSP) (Hallett, 
2000; McNeil et al., 2013; Rösler, 2001; Rossi, Hallett, Rossini, Pascual-Leone, & Group, 
2009; Taylor & Gandevia, 2001). The cSP can last up to 300 ms and is believed to be influenced 
by both spinal inhibitory (up to 150 ms of the cSP) (Yacyshyn, Woo, Price, & McNeil, 2016) 
and cortical mechanisms (which predominately contribute to the later period) (Chen, Lozano, 
& Ashby, 1999; McDonnell, Orekhov, & Ziemann, 2006), the latter of which is believed to 
result from activation of an intracortical inhibitory process mediated by long-lasting gamma-
aminobutyric acid (GABA)B receptors. In turn, the cSP is commonly used as an indicator of an 
intracortical inhibitory process that can influence voluntary neural drive to the muscle. 
Therefore, by imposing TMS pulses at rest and during voluntary contraction, subsequent MEP 
amplitude and cSP can be used to give insight into cortical and corticospinal mechanisms 
contributing to force loss after repeated bouts of high-intensity contractions, such as those 
performed during strength training and other forms of high-intensity exercise. 
17 
 
 
Figure 1.2. Sample recording of a TMS pulse during contraction. The MEP appears as a sharp spike in 
the EMG signal followed by a period of near silence (cSP). EMG then returns as the contraction 
recommences. 
 
1.3.2 Motor neurone excitability and tendon vibration 
In addition to TMS, tendon vibration methods can be used to assess MN excitability 
(Desmedt & Godaux, 1978; McNeil, Giesebrecht, Khan, et al., 2011; McPherson, Ellis, 
Heckman, & Dewald, 2008; Mottram, Suresh, Heckman, Gorassini, & Rymer, 2009; Suresh, 
Wang, Heckman, & Rymer, 2011; Trajano, Seitz, Nosaka, & Blazevich, 2014). At high 
frequencies (e.g. > 70 Hz), tendon vibration recruits motor units through the activation of Ia 
afferents arising from muscle spindles that induce progressive excitation to the homonymous 
MNs, and facilitates PICs in those MNs (Frigon et al., 2011; Heckman & Binder, 1988). The 
presence of this PIC can be seen as a slow progressive increase in isometric force during the 
tendon vibration sequence, as well as a visibly sustained force that persists beyond the cessation 
of vibration (Heckman et al., 2005). When performed alone, tendon vibration has been shown 
to induce small force outputs resulting from the recruitment of low-threshold motor units 
(Gorassini, Bennett, & Yang, 1998; Kamen, Sullivan, Rubinstein, & Christie, 2006; Kiehn & 
Eken, 1997). However, higher-force outputs may be elicited by imposing bursts of electrical 
stimulation simultaneously with tendon vibration to recruit higher-threshold motor units. With 
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this technique, forces of up to 50% of maximal contraction have been achieved, indicating the 
presence of fatigue-resistant as well as fast-fatigable motor unit recruitment (Magalhães, de 
Toledo, & Kohn, 2013; Magalhães & Kohn, 2010). This technique thus provides a unique 
opportunity to investigate PIC behaviour in humans (Trajano et al., 2014) and potentially its 
modulation with fatigue. 
 
1.3.3 Caffeine and its modulation of corticospinal excitability 
Although the techniques described above should provide a reasonable indication of 
motor neuronal tract efficiency and PIC amplitudes after an acute bout of maximal or near-
maximal muscular contractions, they are not able to determine the motor neuronal site 
primarily responsible for the changes in motor unit discharge rate. Caffeine is often used to 
improve performance in fatiguing contractions, including those in strength training, and it is 
known to elicit both supraspinal (Cappelletti, Daria, Sani, & Aromatario, 2015; Nehlig, Daval, 
& Debry, 1992; Walton, Kalmar, & Cafarelli, 2002) and spinal (i.e. motor neuronal) (Walton, 
Kalmar, & Cafarelli, 2003) effects. Based on previous evidence, caffeine upregulates PIC 
amplitudes, partly because it affects noradrenergic and serotonergic drive (Walton et al., 2002) 
which positively augments PIC amplitudes and raises the resting membrane potential towards 
threshold (Heckman et al., 2008), and partly because it competes with adenosine on the post-
synaptic membrane to increase membrane conductance (Kalmar & Cafarelli, 2004a; Walton et 
al., 2002). Additionally, caffeine increases the likelihood of self-sustained firing of MNs, which 
might indicate the presence of PICs (Walton et al., 2002). Thus, caffeine is believed to improve 
MN excitability at the somato-dendritic end of the MN and might rescue MN excitability, and 
hence force production, during fatigue. However, one could speculate also that caffeine might 
activate serotonergic receptors at the axon hillock and thus contribute to the loss of excitability 
(Cotel et al., 2013). A reasonable hypothesis, therefore, is that caffeine’s positive pre-somatic 
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effects must dominate if spinal excitability increases and the force decline during fatiguing 
contractions is attenuated, but that its potential post-somatic effects must dominate (or that it 
had no discernible pre-somatic effect) if fatigue is notable. 
 
1.4 Summary 
 
This review provides evidence that both peripheral and central mechanisms contribute 
to the loss of force during fatiguing exercise. Regarding peripheral mechanisms, reduced E-C 
coupling efficiency due to increased metabolite accumulation, as well as reduced sarcoplasmic 
reticulum Ca2+ release and sensitivity of the contractile proteins to Ca2+ are likely contributors 
to the force loss seen during fatigue. Regarding central mechanisms, force loss may be due to 
reduced supra-spinal drive, spinal excitability and/or impaired MN facilitation processes. 
However, a paucity of research has investigated these mechanisms during high-intensity yet 
submaximal activities such as strength training where fatigue is elicited. It is therefore 
necessary to identify whether these mechanisms contribute to force loss and hence influence 
fatigue. Such research should improve strategies undertaken by strength coaches and clinicians 
for influencing strength, power and hypertrophy. 
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1.5 Aims of the thesis 
 
The major aims of the present thesis are as follows: 
 
Question 1: What is the relative contribution of central vs. peripheral mechanisms to 
the force loss after an acute bout of repeated fatiguing high-intensity muscular contractions 
performed with short periods of rest between bouts of contractions? 
Hypothesis 1: It was hypothesised that both central and peripheral mechanisms would 
account for the loss in force following repeated fatiguing high-intensity muscular contractions, 
but that peripheral mechanisms would take longer to recover than central mechanisms. 
 
Question 2: Does corticospinal excitability and PIC-mediated facilitation of the MN 
pool decrease following an acute bout of repeated fatiguing, high-intensity muscular 
contractions decrease? 
Hypothesis 2: It was hypothesised that corticospinal excitability and PIC amplitude 
would be reduced following fatiguing, high-intensity muscular contractions, but that these 
would recover relatively quickly following the exercise. 
 
 Question 3: What are the effects of caffeine ingestion on corticospinal and MN 
excitability and does the ingestion of caffeine attenuate the loss of force following repeated, 
high-intensity muscular contractions? 
Hypothesis 3: It was hypothesised that the ingestion of caffeine would maintain 
corticospinal and MN excitability during repeated high-intensity muscular contractions and 
minimise the loss of maximum force generating capacity. 
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Methods 
The study was conducted in two parts; Experiment 1 and Experiment 2. 
 
2.1.1 Participants 
Sixteen resistance trained men volunteered to participate in Experiment 1 (age (mean ± 
SD), 25.8 ± 3.6 y; height, 1.71 ± 0.3 m; body mass, 92.3 ± 24.3 kg) whilst seventeen 
volunteered in Experiment 2 (age, 25.5 ± 3.7 y; height, 1.76 ± 0.06 m; body mass, 86.6 ± 15.8 
kg). A total of eight participants volunteered to participate in both experiments. All participants 
completed a Physical Activity Readiness Questionnaire and a TMS Readiness Questionnaire 
and reported no lower-limb neuromuscular disorders or contraindications to the safe use of 
TMS (i.e. no neurological disorders, medical implants or use of medications that alter neuronal 
activity). The participants volunteered on the basis that they were involved in a lower-body 
resistance training program for muscular strength and/or power development for at least 12 mo, 
had no known neurological or cardiovascular disease, and reported a minimal (<200 mg/day) 
caffeine consumption. They were required to abstain from taking any stimulants or depressants, 
including caffeine for at least 12 h and alcohol for at least 24 h, prior to testing and to refrain 
from performing sports or hard exercise training for 24 h prior to each experimental session. 
Written informed consent was obtained from all participants and all procedures in the study 
were conducted in accordance with the Declaration of Helsinki and were approved by the Edith 
Cowan University Human Research Ethics Committee. 
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Experiment 1: The effect of fatigue and recovery in response to repeated 
high-intensity muscle contractions on cortico-motoneuronal pathway 
efficiency. 
 
2.2.1 Study design and overview 
Participants visited the laboratory on three separate occasions at the same time of the 
day separated by a minimum of 72 h. In Session 1, the participants were familiarised with 
isometric plantar flexion test protocol and electrical nerve and magnetic cortical stimulation 
procedures. The subsequent two visits (non-caffeine and caffeine conditions) were used to 
examine the effect of fatiguing, repeated high-intensity muscle contractions on corticospinal 
excitability and neural drive to the muscle (described below). The exact number and intensity 
of muscle contractions was performed in the caffeine condition as in the non-caffeine condition, 
however the participants ingested 3 mgkg-1 body mass of caffeine 1 h prior to the 
commencement of the trial in the caffeine condition. Participants’ peak isometric strength and 
neuromuscular function were tested before and immediately, 10 and 20 min after completion 
of a series of high-intensity, intermittent muscular contractions of the plantar flexors of the 
right leg (i.e. the fatiguing exercise protocol; see Figure 2.1 below for details). Each 
experimental session took place at the same time of day. 
 
2.2.2 Non-caffeine condition (Session 2) 
Upon arrival, each participant performed a standardised warm-up on a Monark cycle 
ergometer consisting of 5 min stationary cycling at 60 rpm with a 1-kg resistance. The 
participant was then seated on an isokinetic dynamometer (Biodex System 3 Pro, Biodex 
Medical System, Shirley, New York, USA) with the knee fully extended (0°) and ankle in the 
neutral position (0°; plane of foot relative to tibia) with the sole of foot perpendicular to the 
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shank and the lateral malleolus of the fibula aligned with the dynamometer’s centre of rotation. 
To minimise movement of the dynamometer system during MVCs, the method of Cannavan, 
Coleman, and Blazevich (2012) was used. First, the seat was positioned so that the knee angle 
was ~30° with the leg relaxed, then the leg was straightened so that the chair and dynamometer 
head were pressed apart, the mechanical compliance of the system reduced, and the leg acted 
like a strut with the muscles relaxed. Torque values were then expressed relative to the new 
baseline torque. The participant’s upper body, knee and ankle were firmly secured to the 
dynamometer with straps and the contralateral leg rested on stool to avoid unwanted 
movements. Visual feedback of torque data was provided by a television monitor placed ~2 m 
in front of participants. All data was recorded synchronously at 2,000 Hz on a personal 
computer running LabChart software (version 8.1.5, ADInstruments, NSW, Australia) using a 
16-bit analogue-to-digital converter (PowerLab 16/35, ADInstruments). Once seated the 
participant performed five 3-s isometric plantar flexions ranging from 20-100% of perceived 
maximum effort with 30 s of rest between contractions as a warm-up. 
 
2.2.3 Tibial Nerve Stimulation 
Percutaneous tibial nerve stimulation was used to evoke M-waves to assess potential 
changes in peripheral (muscle) function as well as to normalise both motor-evoked potential 
(MEP) and electromyography (EMG) measurements, as described below. After the warm-up, 
the stimulation intensity required to evoke the maximal M-wave amplitude was determined by 
delivering single 0.2-ms square-wave pulses to the tibial nerve of the right leg using a constant-
current stimulator (DS7H, Digitimer Ltd, Welwyn Garden City, UK). The cathode electrode 
(pick-up area 77 mm2; Unilect 4535M, Ag/AgCl, Unomedical Ltd, Redditch, UK) was 
positioned over the tibial nerve in the popliteal fossa and the anode electrode (5 × 9 cm; Dura-
Stick Plus, DJO Global LLC., Vista, USA) was positioned proximal to the patella. An elastic 
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band was placed around the knee over the cathode to hold the cathode in a constant position 
and to apply constant pressure throughout testing sessions. The stimulation site that elicited the 
greatest soleus (SOL) M-wave response at a submaximal stimulation intensity was located by 
a hand-held cathode electrode pen (Compex Motor Point Pen, DJO Global LLC., Vista, USA). 
The stimulation intensity for SOL Mmax was determined by increasing stimulator intensity in 
5-10 mA increments from a sub-motor threshold intensity, where no evoked response was 
observed, until the M-wave amplitude plateaued, with 10-s intervals between stimuli while the 
participants were at rest in the isokinetic dynamometer. The stimulus intensity eliciting resting 
SOL Mmax was then increased by 50% to ensure a supramaximal stimulus intensity (150%) was 
used and to account for any depression in MN responsiveness during fatigue. The 
supramaximal stimulus intensity for Mmax was held constant throughout the experiment. 
 
2.2.4 Transcranial magnetic stimulation (TMS) procedure 
Transcranial magnetic stimulation (TMS) hotspot and test intensities were then 
determined. Prior to the experiment, each participant was familiarised with the device and 
completed a TMS safety checklist to screen for any contraindications. Magnetic stimuli were 
delivered to the contralateral (i.e. left) primary motor cortex by a double-cone coil (110 mm 
diameter) attached to a Magstim 2002 stimulator. The coil was orientated to induce a posterior-
anterior current. To find the optimum stimulation site (hotspot), the coil was moved over the 
motor cortex area contralateral to the plantar flexors of the right leg in 1-cm increments 
laterally, anteriorly and posteriorly to the vertex using a pre-defined grid marked on a cap worn 
by participants which was set according to the intersection of lines between the inion and nasion 
and the left and right ear targus. The position that elicited the greatest average of three SOL 
MEPs while evoking minimal tibialis anterior (TA) response (< 50% of SOL MEP) was marked 
on the cap to ensure that accurate positioning was maintained. A custom-made coil holder and 
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an experienced investigator maintained coil placement throughout the experiments. Using 
Parameter Estimation by Sequential Testing (Awiszus, 2003) procedures through the TMS 
Motor Threshold Assessment Tool software (MTAT 2.0; (Awiszus and Brockhardt, 2011; 
Silbert et al., 2013a) resting motor threshold (RMT) was determined as the lowest TMS 
intensity that yielded a peak-to-peak resting SOL MEP amplitude of at least 60 μV [mean ± 
SD; non-caffeine condition (NON-CAF): 55.7 ± 10.5% of maximal stimulator output (MSO); 
caffeine condition (CAF): 53.1 ± 7.4 % MSO]. TMS intensity was then set at 120% of RMT 
(NON-CAF: 62.7 ± 19.9% MSO; CAF: 59.8 ± 17.3% MSO) and this intensity was kept 
constant throughout the sessions (Soto, Valls-Solé, Shanahan, & Rothwell, 2006). 
 
2.2.5 Fatiguing exercise protocol and test procedures 
The fatiguing exercise protocol consisted of 6 sets of isometric calf contractions (3 s 
contraction/2 s rest) reaching a target level of 85% MVC with a 90-s rest between sets. Each 
set of contractions was completed when the required torque level was not attained on two 
consecutive repetitions, i.e. each set contained a different number of contractions, with fewer 
repetitions performed in the latter sets of the protocol. The test protocol was completed 180 s 
before (PRE) and immediately (POST), 10 min (POST-10) and 20 min (POST-20) after 
completing the fatiguing exercise protocol. The test protocol consisted of eight resting TMS 
pulses each separated by 5 s, six 3-s MVCs with superimposed TMS pulses separated by 30 s, 
and three Mmax measurements. Participants were instructed to perform the MVCs with the 
greatest possible rate of force development, to hold for 3 s (indicated by the experimenter) and 
then to relax as quickly as possible. Participants received strong verbal encouragement and 
visual feedback of performance from each MVC completed. Maximal voluntary isometric 
plantar flexion torque from the six MVCs at each time point were averaged and used as a 
measure of voluntary force production. 
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Figure 2.1. Experiment 1 design. Participants completed PREP before being tested before (PRE) and 
immediately (POST), 10 min (POST-10) and 20 min (POST-20) after the fatiguing contractions. The 
test protocol consisted of eight resting TMS pulses (white arrows), six active TMS pulses (black arrows) 
superimposed during MVC (active TMS) and 3 resting Mmax stimuli (grey arrows). 
 
2.2.6 Measurement of muscle activity (EMG) 
Surface EMG was used to record muscle activity as well as evoked responses to TMS 
(i.e. MEP and cSP) and tibial nerve stimulation (Mmax). Voluntary EMG was recorded from 
SOL, medial gastrocnemius (MG) and TA of the right leg using bipolar configurations of two 
Ag/AgCl self-adhesive electrodes (inter-electrode distance of 2 cm; Blue Sensor N-00-S, 
28mm2, Ambu, Ballerup, Denmark). SOL EMG location was ~3 cm below the distal head of 
MG. MG EMG was positioned over the most prominent area of MG when isometrically 
contracted and TA EMG was placed 1/3 of the distance between the lateral epicondyle of the 
tibia and the medial malleolus. To obtain clearer evoked responses (i.e. MEP, cSP, and Mmax 
data) a pseudo-monopolar EMG configuration was also used over SOL (SOLPSU) The active 
electrode was positioned just anterior to the SOL bipolar EMG electrodes and the dispersive 
electrode ~3 cm superior to the medial malleolus and over the Achilles tendon-soleus muscle-
tendon junction (Blazevich, et al., 2012). The reference electrodes were positioned on the 
medial and lateral malleoli of the ankle. The skin beneath the electrodes was shaved, abraded 
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and cleaned with alcohol to reduce inter-electrode resistance below 5 kΩ. EMG was sampled 
at a 2000 Hz analogue-digital conversion rate using a Dual BioAmp EMG system 
(ADInstruments, NSW, Australia) and band-pass filtered (20-500 Hz) using LabChart Software 
(PowerLab System, ADInstruments, v. 8.1.5, NSW, Australia).  SOL, MG and TA muscle 
activities during plantar flexion were expressed as root mean square EMG amplitudes (500-ms 
averaging window) and SOL and MG normalised to Mmax amplitude (EMG/M) (Kalmar & 
Cafarelli, 2004b). In addition, both SOL/M and MG/M were averaged to obtain a global 
measure of triceps surae EMG (TS/M) (Trajano, Seitz, Nosaka, & Blazevich, 2013). To 
measure MEP and Mmax amplitudes, EMG data remained unfiltered and the peak-to-peak 
amplitude was used. The TMS-induced EMG cortical silent period (cSP) duration was 
determined by visual inspection of the SOLPSU EMG records and measured from the onset of 
the MEP to the return of voluntary EMG activity after the silent period (Damron, Dearth, 
Hoffman, & Clark, 2008; Säisänen et al., 2008). Changes in MEP/M ratio and cSP were used 
to assess corticospinal excitability and intracortical inhibition, respectively. 
 
2.2.7 Caffeine condition (Session 3) 
To ensure full recovery of force production in the plantar flexors after Session 2, 
Session 3 took place >72 h after Session 2. This session was completed identically to Session 
2 with the exception that participants ingested 3 mgkg-1 (Walton et al., 2003; Walton et al., 
2002) of U.S.P grade caffeine in tablet form (No-Doz, Key Pharmaceuticals Pty Ltd, Macquarie 
Park, NSW) 1 h prior to the commencement of the experiment (Graham, Rush, & Soeren, 
1994). This allowed the testing of the effect of caffeine ingestion on fatigue-induced reductions 
in corticospinal and MN excitability and force production. During the exercise protocol, the 
intensity and number of repetitions attained in Session 2 were repeated exactly by providing a 
visual target of the plantar flexor torque level to be obtained on a repetition-by-repetition basis. 
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As caffeine has the potential to reduce the magnitude and rate of fatigue, and potentially 
increase the rate of recovery, the caffeine condition was always completed after the non-
caffeine condition to ensure that participants were able to precisely repeat the required number 
and intensity of contractions. This ensured that direct comparisons of physiological changes 
associated with fatigue could be made between the non-caffeine and caffeine sessions. Blinding 
of condition was not considered to be necessary since the aim of the trial was not to assess the 
possible ergogenic effects of caffeine, but to use it as a pharmacological intervention to further 
probe potential physiological changes underpinning fatigue. Finally, chances of an order effect 
were minimised by allowing the participant to practice the plantar flexion task during the 
familiarisation session. 
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Experiment 2 – The effect of fatigue and recovery during repeated high-
intensity muscle contractions on MN facilitation (PIC amplitude) and Ca2+ 
kinetics. 
 
2.3.1 Study design and overview 
Experiment 2 was conducted using the same experimental design as in Experiment 1. 
Participants were familiarised in Session 1, tested without caffeine in Session 2 and then tested 
after caffeine ingestion in Session 3, each at the same time of the day and separated by a 
minimum of 72 h. 
 
2.3.2 Non-caffeine condition (Session 2) 
Upon arrival, each participant performed a cycle warm-up as done in Experiment 1 
before being seated on an isokinetic dynamometer. The stimulation intensity required to evoke 
the maximal M-wave amplitude was then determined (see above for Mmax set-up). Once seated 
the participant performed five 3-s isometric plantar flexions ranging from 20-100% of 
perceived maximum effort with 30 s of rest between contractions, followed by two additional 
MVCs. The best score from the three MVCs was recorded and used to attain the stimulation 
intensities for subsequent PIC and Ca2+ testing (see Figure 2.3 below for experimental design). 
 
2.3.3 Muscle stimulation procedures (20:80 Hz torque ratio and torque response to 
constant vs. variable frequency train stimulations) 
A constant current electrical stimulator (DS7, Digitimer Ltd, Welwyn Garden City, UK) 
was used to deliver an electrical square-wave stimulus (0.5-ms pulse width) to the plantar flexor 
muscle belly through two self-adhesive electrodes (5 × 9 cm; Dura-Stick Plus, DJO Global 
LLC., Vista, USA). The cathode was placed on the medial and lateral gastrocnemius muscle 
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bellies, where greatest motor response was elicited (i.e. assumed motor point) and the anode 
was placed over the distal myotendinous junction of soleus. Two elastic bands were placed 
around the calf, one over each electrode, which prevented the electrodes from falling off and 
applied a constant pressure throughout testing sessions. 
For all tetanic stimulations, the intensity necessary to reach 50% of MVC with a 0.5-s 
80-Hz tetanic stimulation was used (Martin et al., 2004). Three tetanic stimulations of the same 
duration (0.5 s) were delivered to test for excitation-contraction (E-C) coupling efficiency: 1) 
20 Hz train; 2) variable frequency “catch inducing” train (i.e. 20 Hz train with the first two 
pulses at 100 Hz; VFT); and 3) 80 Hz train. The peak torque produced by the 20-Hz and 80-
Hz stimulations were used to calculate the 20:80 Hz torque ratio, which was used as a measure 
of E-C coupling efficiency (Martin et al., 2004). The ratio of the torques evoked by the variable 
vs. constant frequency trains was used to estimate the muscle’s capacity to utilise a high-
frequency double discharge at contraction onset, which is hypothesised to be strongly affected 
by Ca2+ sensitivity of the muscle (Binder‐Macleod & Kesar, 2005; Burke et al., 1970). 
 
2.2.4 Motor neurone facilitation (tendon vibration superimposed with neuromuscular 
electrical stimulation) 
A combined tendon vibration plus muscle stimulation (VIB+STIM) technique was used 
to estimate PIC magnitude (Trajano et al., 2014). With the participant’s ankle in a slightly 
dorsiflexed position (-10°), the Achilles tendon of the right leg was mechanically vibrated at 
115 Hz (1-mm deflections) by a hand-held vibrator (Vibrasens, Techno Concepts, Mane, 
France). The vibrator was held with steady pressure against a marked point in line with the 
medial malleolus on the Achilles tendon for 33 s. After the first 10 s of vibration, five 2-s bursts 
of neuromuscular electrical stimulation at a frequency of 20 Hz were superimposed on the 
ongoing tendon vibration at 4-s intervals (see Figure 2.2). The experimental setup for muscle 
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stimulation was the same as that used to measure E-C coupling efficiency (see Muscle 
stimulation procedures above). For all electrical stimulations, an intensity that elicited a torque 
response of 20% MVC with a 0.5-s 20 Hz tetanic stimulation was used. During the VIB+STIM 
protocol, participants were instructed to hold onto the shoulder straps and not voluntarily 
activate the plantar- or dorsi-flexor muscles. The left leg was positioned on a stool so that both 
legs were straight which prevented any extraneous movement throughout the test. To further 
reduce the chances of voluntary calf activation, participants were asked to count in two’s from 
zero (i.e. 0, 2, 4, 6, etc.) at a self-selected pace throughout the VIB+STIM protocol. 
 
Figure 2.2. Schematic representation of the tendon vibration and superimposed tibial nerve 
stimulation protocol used to elicit reflexive muscular contractions. 
 
2.2.5 Test procedures 
Electrically evoked torque (20 Hz, VFT and 80 Hz) and VIB+STIM measurements 
were performed 7 min (within-day control; CON) and 2 min (PRE) prior to completion of the 
same fatiguing exercise protocol performed in Experiment 1 (see Fatiguing exercise protocol 
and test procedures above). Upon completion of the exercise protocol, electrically-evoked 
torque and VIB+STIM measurements were performed followed by one MVC and one Mmax 
measurement. These were again repeated 10 min (POST-10) and 20 min (POST-20) after the 
fatiguing exercise protocol. 
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Figure 2.3. Experiment 2 design. Participants completed PREP, followed by three MVCs and M-waves, 
Control and PRE. Upon completion of the fatiguing exercise protocol, the participants were tested at 
POST, POST-10 and POST-20. The test protocol at Control and PRE consisted 20 Hz (blue arrow), 
VFT (red arrow), 80 Hz (green arrow) stimulations and VIB+STIM (yellow arrow). The POST test 
protocol consisted of 20 Hz, VFT, 80 Hz stimulations, VIB+STIM, one MVC and one Mmax 
measurement. 
 
2.2.6 Voluntary and evoked torque measurements 
Maximal voluntary isometric plantar flexion torque was used as a measure of voluntary 
force production. Evoked torque from the 20 Hz, 80 Hz and VFTs were analysed as the peak 
torque attained from each trial. Evoked torque from the VIB+STIM protocol (see Figure 2.4) 
was analysed as the mean torque in a 1-s window at two different time points during the 
protocol: (1) during vibration starting 500 ms after completion of the 5th (last) burst of tibial 
nerve stimulation (torque during vibration; Tvib), and (2) 500 ms after the vibration was ceased 
(sustained torque; Tsust). As plantar flexor muscles impose a small passive torque even when 
the muscle is relaxed, Tvib and Tsust torque values were normalised and presented as changes 
from the baseline (resting) value.  
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Figure 2.4. Example of the torque elicited during the combined tendon vibration plus tibial nerve 
stimulation protocol and time points at which torque is recorded. Tvib, torque is measured after the 5th 
(last) bout of electrical stimulation; Tsust, torque is measured 500 ms after vibration cessation (self-
sustained torque). 
 
2.2.7 Measurement of muscle activity (EMG) 
EMG setup, recording and analysis was the same as Experiment 1 (see above for 
details). 
 
2.2.8 Caffeine condition (Session 3) 
Session 3 took place >72 h after Session 2. This session was completed identically to 
Session 2 with the exception that participants ingested 3 mgkg-1 (see Experiment 1; Session 3 
above for details). 
 
2.2.9 Statistical analysis 
Prior to analysis, the data were assessed for normality of distribution, homogeneity of 
variance (Levene’s test) and sphericity (Mauchly’s test). In Experiment 1, a two-way analysis 
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of variance (ANOVA) with repeated measures was used to compare changes in voluntary 
torque, MEP, MEP/M ratio cSP duration Mmax and TA variables between non-caffeine (NON-
CAF) and caffeine (CAF) conditions and over time (PRE, POST, POST-10 and POST-20). A 
two-way repeated measures multivariate ANOVA (MANOVA) was performed to compare 
changes in SOL/M, MG/M, and TS/M between conditions and over time. Coefficient of 
variation (CV) was calculated to determine the variability in voluntary torque production over 
time and between conditions. 
In Experiment 2, a two-way ANOVA with repeated measures was used to compare 
changes in voluntary torque, evoked torque from 20 Hz, 80 Hz and VFTs, 20:80 Hz and 20:VFT 
ratios, Tvib, Tsust, Mmax and TA variables between conditions (NON-CAF vs. CAF) and over 
time (PRE, POST, POST-10 and POST-20). A two-way repeated measures MANOVA was 
performed to compare changes in SOL/M, MG/M, and TS/M between conditions and over time. 
In cases where Mauchly’s Test of Sphericity was violated, Greenhouse-Geisser corrections 
were used. When statistical differences were observed, post-hoc tests were used as appropriate 
(see Results) to determine the location of the differences. Pearson’s product-moment 
correlations were calculated to determine relationships between changes in torque, EMG, 
MEPs and cSP immediately and 10 min after exercise in Experiment 1, and changes in torque, 
EMG, evoked torque and VIB+STIM measurements in Experiment 2. Statistical analysis was 
performed using SPSS version 24.0 (SPSS Inc., Chicago IL, USA). All data are reported as 
mean  SD in text (and mean  SE in graphs), confidence intervals (95%) and Hedges’ g effect 
sizes. Statistical significance was accepted at an α level of 0.05. 
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Results 
Experiment 1: The effect of fatigue and recovery in response to repeated 
high-intensity muscle contractions on cortico-motoneuronal pathway 
efficiency. 
Example data traces for one participant in both the non-caffeine and caffeine conditions 
are presented in Figures 3.1 and 3.2, respectively. 
 
Figure 3.1. Traces of raw data from Experiment 1. Example data obtained from a single participant in 
the non-caffeine session immediately before (PRE) and immediately (POST), 10 min (POST-10) and 
20 min (POST-20) after the exercise protocol. Decreases in MVC torque (first row), MEP amplitude 
(second row) and SOLRMS are noticeable immediately after the exercise protocol. 
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Figure 3.2. Traces of raw data from Experiment 1. Example data obtained from a single participant in 
the caffeine session immediately before (PRE) and immediately (POST), 10 min (POST-10) and 20 
min (POST-20) after the exercise protocol. Decreases in MVC torque (first row), MEP amplitude 
(second row) and SOLRMS are noticeable immediately after the exercise protocol. 
 
3.1.1 Torque 
Significant main effects of time (F(3,15) = 34.391, p = 0.000; see Figure 3.3) and 
condition (F(1,15) = 10.843, p = 0.005; see Figure 3.4) were observed for maximal plantar flexion 
torque, however there was no condition-by-time interaction effect (F(2.655,15) = 1.489, p = 
0.235). With respect to the time effect, pooled data (pooled between caffeine and non-caffeine 
conditions) for torque decreased immediately POST (-12.2 ± 6.5% (CI = -22, -3%), p < 0.001, 
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g = 0.642) and did not recover by POST-10 (-6.3 ± 6.1% (-16, 4%), p < 0.001, g = 0.315) or 
POST-20 (-4.8 ± 6.5% (-15, 5%), p = 0.002, g = 0.239) relative to before exercise (PRE). 
Follow-up repeated measures ANOVAs (RM ANOVAs) examining the changes in each 
condition (caffeine and non-caffeine conditions separate) revealed a decrease in torque at POST 
in both NON-CAF (-12.7 ± 4.6% (-26, 0%), p < 0.001g = 0.697) and CAF (-11.7 ± 7.9% (-26, 
2%), p < 0.001, g = 0.585) conditions compared with PRE. At POST-10, torque was still 
reduced in both NON-CAF (-7.8 ± 4.9% (-22, 6%), p < 0.001, g = 0.394) and CAF (-4.8 ± 
6.8% (-19, 10%), p = 0.013, g = 0.238). Torque did not return to baseline within the 20-min 
recovery period in either NON-CAF (-6.2 ± 6.7%, (-20, 8%), p = 0.002, g = 0.298) or CAF (-
3.3 ± 6.1% (-18, 11%), p = 0.044, g = 0.179). 
With respect to the condition effect, Post-hoc analyses indicated that the between-
condition effect (with a greater torque production observed in CAF than NON-CAF) resulted 
from significant differences at POST-10 (6.9 ± 7.4% greater in CAF compared to NON-CAF 
(-9, 22%), p = 0.003, g = 0.309) and POST-20 (6.8 ± 7.6% greater in CAF compared to NON-
CAF (-9, 21%), p = 0.004, g = 0.287) with no statistical difference being observed at PRE (3.4 
± 6.2% greater in CAF compared to NON-CAF (-11, 18%), p = 0.6, g = 0.171) or POST (4.7 
± 9.5% greater in CAF compared to NON-CAF (-10, 20%), p = 0.092, g = 0.287).  
Finally, CV for torque did not vary over time (F(1.686,15) = 0.825, p = 0.431) or between 
conditions (F(1,15) = 0.752, p = 0.545). The number of repetitions performed throughout the 
exercise protocol did not statistically differ between conditions (p = 0.908). Of the 16 
participants, 9 replicated exactly the number of reps performed in the non-caffeine session, 4 
missed by one rep, 2 missed by two reps and 1 missed by six reps. 
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3.1.2 Muscle activity 
SOL/M, MG/M, TS/M and TA EMG measured at PRE, POST, POST-10 and POST-20 
are presented in Table 3.1. In SOL/M, a significant main effect of time (F(3,15) = 6.233, p = 
0.001) was detected but no condition (F(1,15) = 2.670, p = 0.123) or condition-by-time 
interaction effects (F(3,15) = 0.088, p = 0.966) were observed. With respect to the time effect, 
SOL/M decreased immediately POST (-7.6 ± 14.9% (-38, 22%), p = 0.003, g = 0.186) but 
recovered by 10 min (-3.1 ± 18.6% (-25, 32%), p = 0.599, g = -0.049).  
In MG/M, significant main effects of time (F(3,15) = 8.086, p < 0.001) and condition 
(F(1,15) = 7.581, p = 0.015) were observed, however there was no condition-by-time interaction 
effect (F(3,15) = 1.628, p = 0.196). With respect to the time effect, a non-significant decrease of 
-3.9 ± 14.3% (-25, 14%, p = 0.076, g = 0.205) was observed which recovered by 10 min (4.4 
± 13.6% (-17, 22%), p = 0.223, g = -0.135). Follow-up RM ANOVAs examining the changes 
in each condition revealed no effect of time on MG/M in NON-CAF (F(3,15) = 1.615 p = 0.199), 
however MG/M decreased in CAF at POST (-6.6 ± 9.3% (-27, 9%), p = 0.013, g = 0.326) but 
recovered by POST-10 (4.1 ± 11.3% (-15, 24%), p = 0.237, g = -0.129). 
With respect to the condition effect, Post-hoc analyses indicated that the between-
condition effect (greater MG/M observed in CAF than NON-CAF) resulted from significant 
differences at PRE (22.0 ± 33.8% greater in CAF compared to NON-CAF (-3, 36%), p = 0.02, 
g = 0.607), POST-10 (22.1 ± 32.9% greater in CAF compared to NON-CAF (-3, 34%), p = 
0.024, g = 0.559) and POST-20 (26.3 ± 29.9% greater in CAF compared to NON-CAF (-3, 
40%), p = 0.002, g = 0.821), with no statistical difference being observed at POST (17.1 ± 
33.0% greater in CAF compared to NON-CAF (-9, 31%), p = 0.111, g = 0.415). 
In TS/M, significant main effects of time (F(3,15) = 9.102, p < 0.001; Figure 3.3) and 
condition (F(1,15) = 15.761, p = 0.001; Figure 3.4) were observed, however there was no 
condition-by-time interaction effect (F(3,15) = 1.628, p = 0.196). With respect to the time effect, 
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TS/M decreased immediately POST (-5.8 ± 12.6% (-30, 15%), p = 0.024, g = 0.243) but 
recovered by 10 min (-3.6 ± 13.2% (-16, 22%), p = 0.242, g = -0.108). Follow-up RM ANOVAs 
examining the changes in each condition revealed no effect of time on TS/M in NON-CAF 
(F(1.907,15) = 2.832 p = 0.078), however TS/M decreased in CAF at POST (-7.4 ± 12.1% (-25, 
8%), p = 0.033, g = 0.339) and then recovered by POST-10 (3.0 ± 11.1% (-15, 19%), p = 0.428, 
g = 0.092). No correlations were observed between changes in EMG/M variables and changes 
in torque. 
With respect to the condition effect, post-hoc analyses indicated that the between-
condition effect (greater TS/M observed in CAF than NON-CAF) resulted from significant 
differences at PRE (15.1 ± 20.2% greater in CAF compared to NON-CAF (-6, 33%), p = 0.011, 
g = 0.474), POST (11.3 ± 20.5% greater in CAF compared to NON-CAF (-12, 30%), p = 0.048, 
g = 0.302), POST-10 (13.8 ± 17.3% greater in CAF compared to NON-CAF (-8, 30%), p = 
0.003, g = 0.435) and POST-20 (16.6 ± 16.8% greater in CAF compared to NON-CAF (-5, 
34%), p = 0.001, g = 0.548). 
In TA, no significant main effect of time (F(1.746,15) = 1.142, p = 0.328), condition (F(1,15) 
= 0.033, p = 0.858) or condition-by-time interaction effect (F(1.630,15) = 0.471, p = 0.591) was 
observed. 
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Table 3.1. Plantar flexor torque, EMG, and TMS data measured in Experiment 1.  
 PRE POST POST-10 POST-20 
Torque (Nm) 218.3 ± 43.5 191.5 ± 38.9** 204.6 ± 42.8** 207.9 ± 43.0* 
SOL/M 0.031 ± 0.013 0.029 ± 0.013* 0.032 ± 0.012 0.032 ± 0.012 
MG/M 0.036 ± 0.010 0.034 ± 0.009 0.038 ± 0.010 0.038 ± 0.010* 
TS/M 0.068 ± 0.018 0.063 ± 0.017* 0.070 ± 0.018 0.070 ± 0.018 
TA (mV) 0.110 ± 0.041 0.101 ± 0.045 0.105 ± 0.045 0.095 ± 0.040 
MEP (mV) 4.822 ± 1.553 4.272 ± 1.473* 4.455 ± 1.445* 4.300 ± 1.356* 
MEPREST (mV) 1.081 ± 0.588 1.308 ± 0.775 1.177 ± 0.743 1.210 ± 0.796 
MEP/M 0.233 ± 0.089 0.208 ± 0.084* 0.224 ± 0.079 0.219 ± 0.080 
MEPREST/M 0.053 ± 0.029 0.066 ± 0.040 0.060 ± 0.036 0.063 ± 0.040 
cSP (ms) 105.5 ± 16.4 100.4 ± 12.7* 98.8 ± 14.0* 98.7 ± 12.7* 
SOLBP Mmax (mV) 6.626 ± 3.011 6.206 ± 2.913* 5.857 ± 2.782** 5.885 ± 2.773** 
MG Mmax (mV) 12.866 ± 3.392 11.883 ± 3.352** 11.182 ± 3.324** 11.098 ± 3.291** 
SOLPSU Mmax (mV) 21.541 ± 5.058 21.261 ± 4.817 20.388 ± 4.348* 20.332 ± 4.495* 
Values are mean ± SD. Torque, mean torque during maximal voluntary isometric plantarflexion; 
SOL/M, MG/M, TS/M, soleus, medial gastrocnemius and triceps surae (SOL + MG) root-mean square 
EMG normalised to maximal M-wave amplitude; TA, tibialis anterior root-mean square EMG; MEP, 
motor-evoked potential amplitude during MVC; MEPREST, motor-evoked potential amplitude during 
rest; MEP/M, motor-evoked potential amplitude during MVC normalised to Mmax; MEPREST/M, motor-
evoked potential amplitude during rest normalised to Mmax; SOLBP Mmax, soleus bipolar EMG; MG 
Mmax, medial gastrocnemius; SOLPSU Mmax, soleus pseudo-monopolar EMG. *significantly different 
from PRE, p < 0.05, ** p < 0.001. 
 
3.1.3 MEP amplitude 
Active MEP amplitude (MEP) measured at PRE, POST, POST-10 and POST-20 are 
presented in Table 3.1. With respect to MEP, a significant main effect of time (F(2.078,15) = 4.257, 
p = 0.022) was detected, but no condition (F(1,15) = 2.684, p = 0.122) or condition-by-time 
interaction effects (F(2.502,15) = 0.223, p = 0.847) were observed. With respect to the time effect, 
MEP decreased immediately POST (-9.2 ± 22% (-27, 4%), p = 0.026, g = 0.360) and did not 
recover by POST-10 (-6.1 ± 17% (-23, 8%), p = 0.03, g = 0.242) or POST-20 (-9.3 ± 16% (-26, 
4%), p = 0.003, g = 0.354) relative to PRE. 
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3.1.4 MEP/M amplitude 
MEP/M amplitudes measured at PRE, POST, POST-10 and POST-20 are presented in 
Table 3.1 and changes are shown in Figure 3.3. A significant main effect of time on MEP/M 
amplitude (MEP/M) (F(3,15) = 4.339, p = 0.009) was detected, but no condition (F(1,15) = 0.563, 
p = 0.465) or condition-by-time interaction effects (F(3,15) = 0.077, p = 0.972) were observed. 
With respect to the time effect, MEP/M decreased immediately POST (-8.8 ± 20.8% (-29, 8%), 
p = 0.01, g = 0.281) but recovered by 10 min (-0.9 ± 19.6% (-22, 14%), p = 0.184, g = 0.108). 
 
3.1.5 Resting MEP amplitude 
Resting MEP (MEPrest) and MEPrest/M amplitudes measured at PRE, POST, POST-10, 
& POST-20 are presented in Table 3.1. In MEPrest, no significant main effect of time (F(1.881,15) 
= 1.491, p = 0.232), condition (F(1,15) = 0.32, p = 0.860) or condition-by-time interaction effect 
(F(1.938,15) = 0.909, p = 0.413) was detected. In MEPrest/M, no significant main effect of time 
F(3,15) = 1.807, p = 0.182), condition (F(1,15) = 0.222, p = 0.645), or condition-by-time interaction 
effect (F(2.028,15) = 1.356 p = 0.275) was detected. 
 
3.1.6 Cortical silent period 
A significant main effect of time (F(2.204,15) = 7.189, p = 0.002) was detected (Figure 
3.3), but no condition (F(1,15) = 1.181, p = 0.294) or condition-by-time interaction effects 
(F(2.325,15) = 1.930, p = 0.155) were observed. With respect to the time effect, cortical silent 
period (cSP) decreased immediately POST (-3.8 ± 10.2% (-11, 2%), p = 0.016, g = 0.341) and 
remained reduced at POST-10 (-5.7 ± 9.2% (-13, 1%), p = 0.004, g = 0.433) and POST-20 (-
5.6 ± 9.6% (-13, 1%), p = 0.004, g = 0.456). No correlations were observed between changes 
in TMS variables and changes in torque. 
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Figure 3.3. Changes in torque, EMG, MEP/M and cSP measured from PRE to immediately (POST), 
10 min (POST-10) and 20 min (POST-20) after exercise. Changes in A) MVC torque, B) triceps surae 
EMG normalised to M-wave amplitude (EMG/M), C) motor-evoked potential amplitude normalised to 
M-wave amplitude (MEP/M), and D) cortical silent period (cSP). * significantly different from PRE, p 
< 0.05. 
 
 
Figure 3.4. Differences between non-caffeine (NON-CAF) and caffeine (CAF) conditions for torque 
and EMG measured before exercise (PRE) and immediately (POST), 10 min (POST-10) and 20 min 
(POST-20) after exercise. Differences in A) MVC torque, and B) triceps surae EMG normalised to M-
wave amplitude (TS/M). Torque production and EMG were greater in CAF compared to NON-CAF. 
No effect of caffeine was observed in MEP/M or cSP. * significantly different from NON-CAF, p < 
0.05. 
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3.1.7 M-wave amplitude 
Significant main effects of time (F(3,15) = 18.919, p < 0.001) and condition (F(1,15) = 
12.772, p = 0.003) were observed in SOL Mmax, however there was no condition-by-time 
interaction effect (F(3,15) = 0.250, p = 0.861). With respect to the time effect, SOL Mmax 
decreased immediately POST (-6.7 ± 9.6% (-29, 16%), p = 0.01, g = 0.140) and remained 
depressed at 10 min (-12.3 ± 9.3% (-33, 10%), p < 0.001, g = 0.262) and 20 min (-12 ± 8.3% 
(-33, 11%), p < 0.001, g = 0.253). Follow-up RM ANOVAs examining the changes in each 
condition revealed a decrease in SOL Mmax at POST in NON-CAF (-6.7 ± 9.6% (-38, 25%), p 
= 0.014, g = 0.147) that remained depressed at POST-10 (-12.3 ± 9.3% (-43, 18%), p < 0.001, 
g = 0.279) and POST-20 (-12.0 ± 8.3% (-42, 18%), p < 0.001, g = 0.279). In CAF, no statistical 
change in SOL Mmax was detected at POST (-5.0 ± 10.9% (-38, 26%), p = 0.063, g = 0.147), 
however SOL Mmax was depressed at POST-10 (-10.4 ± 10.0% (-43, 21%), p = 0.001, g = 0.243) 
and POST-20 (-9.6 ± 8.5% (-42, 22%), p = 0.001, g = 0.224). 
With respect to the condition effect, post-hoc analyses indicated that the between-
condition effect (smaller SOL Mmax observed in CAF than NON-CAF) resulted from 
significant differences at PRE (12.5 ± 17.0% less in CAF compared to NON-CAF (-44, 16%), 
p = 0.004, g = 0.322), POST (10.5 ± 18.6% less in CAF compared to NON-CAF (-45, 18%), p 
= 0.025, g = 0.300), POST-10 (11.2 ± 12.4% less in CAF compared to NON-CAF (-44, 19%), 
p = 0.003, g = 0.280) and POST-20 (11.3 ± 9.7% less in CAF compared to NON-CAF (-44, 
20%), p < 0.001, g = 0.265). 
In MG Mmax, a significant main effect of time (F(1.698,15) = 53.563, p < 0.001) was 
detected, but no condition F(1,15) = 0.021, p = 0.887) or condition-by-time interaction effects 
(F(1,15) = 4.562, p = 0.019) were observed. With respect to the time effect, MG Mmax decreased 
immediately POST (-8 ± 4.7% (-21, 5%), p = < 0.001, g = 0.288) and remained depressed at 
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10 min (-13.6 ± 7.2% (-26, 0%), p < 0.001, g = 0.495) and 20 min (-14.4 ± 7.5% (-27, -1%), p 
< 0.001, g = 0.523) after exercise. 
In SOL PSU Mmax, a significant main effect of time (F(1.768,15) = 6.809, p = 0.005) was 
detected, but no condition F(1,15) = 0.402, p = 0.536) or condition-by-time interaction effects 
(F(1.469,15) = 1.718, p = 0.206) were observed. With respect to the time effect, SOL PSU Mmax 
decreased immediately POST (-1.1 ± 9.3% (-13, 10%), p = 0.01, g = 0.056) and remained 
depressed at 10 min (-4.6 ± 7.8% (-16, 6%), p < 0.001, g = 0.242) and 20 min (-4.9 ± 7.6% (-
17, 5%), p < 0.001, g = 0.250) after exercise. 
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Experiment 2 – The effect of fatigue and recovery during repeated high-
intensity muscle contractions on MN facilitation (PIC amplitude) and Ca2+ 
kinetics. 
Example data traces for one participant in both the non-caffeine and caffeine conditions 
are presented in Figures 3.5 and 3.6, respectively. 
 
Figure 3.5. Traces of raw data from Experiment 2. Example data obtained from a single participant in 
the non-caffeine session immediately before (PRE) and immediately (POST), 10 min (POST-10) and 
20 min (POST-20) after the exercise protocol. Decreases in MVC torque (first row), reflexive torque 
(second row) and tetanic stimulations are noticeable immediately after the exercise protocol. 
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Figure 3.6. Traces of raw data from Experiment 2. Example data obtained from a single participant in 
the caffeine session immediately before (PRE) and immediately (POST), 10 min (POST-10) and 20 
min (POST-20) after the exercise protocol. Decreases in MVC torque (first row), reflexive torque 
(second row) and tetanic stimulations are noticeable immediately after the exercise protocol. 
 
3.2.1 Torque 
Significant main effects of time (F(1.596,16) = 51.016, p < 0.000; see Figure 3.7) and 
condition (F(1,16) = 8.529, p = 0.011) were observed for maximal plantar flexion torque, 
however there was no condition-by-time interaction effect (F(2.219,16) = 2.985, p = 0.059). With 
respect to the time effect, torque decreased immediately POST (-16.9 ± 7.3% (-25, -8%), p < 
0.001, g = 0.924) and did not recover by POST-10 (-10.8 ± 7.5% (-20, -2%), p < 0.001, g = 
0.603) or POST-20 (-10.2 ± 8% (-19, -1%), p < 0.001, g = 0.544) relative to PRE. Follow-up 
RM ANOVAs examining the changes in each condition revealed a decrease in torque at POST 
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in both NON-CAF (-16.5 ± 7.9% (-30, -4%), p < 0.001, g = 0.899) and CAF (-17.4 ± 6.6% (-
28, -4%), p < 0.001, g = 0.930) conditions compared with PRE. At POST-10, torque was still 
reduced in NON-CAF (-9.9 ± 8.4% (-23, 4%), p < 0.001, g = 0.520) and CAF (-11.7 ± 6.3% (-
24, 0%), p < 0.001, g = 0.682), and did not return to baseline within the 20-min recovery period 
in either NON-CAF (-12.2 ± 9.2% (-26, 2%), p < 0.001, g = 0.615) or CAF (-8.3 ± 5.8% (-21, 
4%), p < 0.001, g = 0.470).  
With respect to the condition effect, post-hoc analyses indicated that the between-
condition effect (greater torque production observed in CAF than NON-CAF), resulted from 
significant differences at PRE (4.7 ± 6.2% greater in CAF compared to NON-CAF (-9, 18%), 
p = 0.008, g = 0.219) and POST-20 (10.3 ± 12.4% greater in CAF compared to NON-CAF (-
6, 24%), p = 0.004, g = 0.410) with no statistical difference being observed at POST (4.6 ± 
9.5% greater in CAF compared to NON-CAF (-10, 19%), p = 0.097, g = 0.230) or POST-10 
(2.9 ± 7.2% greater in CAF compared to NON-CAF (-12, 16%), p = 0.212, g = 0.108). The 
number of repetitions performed throughout the exercise protocol did not statistically differ 
between conditions (p = 0.778). Of the 17 participants, 10 replicated exactly the number of reps 
performed in the non-caffeine session, 5, 1 and 1 participants missed by 2, 3 and 5 repetitions 
respectively. 
 
3.2.2 Muscle activity (electromyography) 
SOL/M, MG/M, TS/M and TA measured at PRE, POST, POST-10 and POST-20 are 
presented in Table 3.2. In SOL/M, the trend towards a time effect did not reach statistical 
significance (F(3,16) = 2.385, p = 0.083), and no condition (F(1,16) = 0.012, p = 0.914) or 
condition-by-time interaction effects (F(3,16) = 1.977, p = 0.132) were observed. 
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In MG/M, significant main effects of time (F(1.815,15) = 8.88, p < 0.002) and condition 
(F(1,16) = 8.399, p = 0.012) were observed, however there was no condition-by-time interaction 
effect (F(2.373,16) = 1.748, p = 0.185). With respect to the time effect, MG/M decreased 
immediately POST (-11.7 ± 23.4% (-37, 0%), p = 0.009, g = 0.482) but recovered by 10 min (-
0.2 ± 23.3% (-32, 5%), p = 0.319, g = 0.36). Follow-up RM ANOVAs examining the changes 
in each condition revealed a decrease in MG/M immediately POST in both NON-CAF (-9.3 ± 
24.4% (-36, 10%), p = 0.039, g = 0.390) and CAF (-14.4 ± 22.1% (-40, 5%), p = 0.01, g = 
0.542) compared to PRE, with a return to baseline at POST-10 in both NON-CAF (4.2 ± 27.7% 
(-26, 23%), p = 0.789, g = 0.041) and CAF (-4.9 ± 16.1% (-31, 19%), p = 0.171, g = 0.166). 
The between-condition effect resulted from significant differences at PRE (7.7 ± 33.5% 
greater in CAF compared to NON-CAF (-18, 36%), p = 0.016, g = 0.255) and POST-20 (15.4 
± 11.9% greater in CAF compared to NON-CAF (-10, 39%), p < 0.001, g = 0.394), with no 
statistical difference being observed at POST (10.1 ± 30.6% greater in CAF compared to NON-
CAF (-21, 30%), p = 0.473, g = 0.132) or POST-10 (5.6 ± 20.7% greater in CAF compared to 
NON-CAF (-18, 29%), p = 0.363, g = 0.147). 
In TS/Mmax, a significant main effect of time (F(3,16) = 6.656, p < 0.001) was detected 
(see Figure 3.7) but no condition (F(1,16) = 0.478, p = 0.501) or condition-by-time interaction 
effects (F(3,16) = 0.2.747, p = 0.055) were observed. With respect to the time effect, TS/M 
decreased immediately POST (-9.8 ± 18% (-24, 8%), p = 0.001, g = 0.251) but recovered by 
10 min (1.5 ± 20.1% (-13, 22%), p = 0.854, g = -0.120). No correlations were observed between 
changes in EMG/M variables and changes in torque. 
In TA, no significant main effect of time (F(3,16) = 0.342, p = 0.795), condition (F(1,16) = 
0.104, p = 0.752) or condition-by-time interaction effect (F(3,16) = 0.729, p = 0.540) was 
observed. 
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 Table 3.2. Plantar flexor torque, EMG, reflexive torque and electrically evoked torque data measured 
in Experiment 2. 
Values are mean ± SD. Torque, peak torque during maximal voluntary isometric plantarflexion; 
SOL/M, MG/M, TS/M, soleus, medial gastrocnemius and triceps surae (SOL + MG) root-mean square 
EMG normalised to maximal M-wave amplitude; TA, tibialis anterior root-mean square EMG; Tvib, 
Tsust, mean torque after the 5th (last) stimulation during vibration and self-sustained torque 500 ms after 
vibration; 20 Hz, 80 Hz, VFT (variable frequency train) tetanic torque values during stimulation trains; 
20:80 Hz, 20:VFT, stimulation train ratios; SOLBP Mmax, soleus bipolar EMG; MG Mmax, medial 
gastrocnemius; SOLPSU Mmax, soleus pseudo-monopolar EMG. *significantly different from PRE, p < 
0.05, ** p < 0.001. 
 
3.2.3 Reflexive torque 
In Tvib, a significant main effect of time (F(4,16) = 2.559, p = 0.048) was detected (see 
Figure 3.7) but no condition (F(1,16) = 0.012, p = 0.916) or condition-by-time interaction effects 
(F(4,16) = 2.460, p = 0.055) were observed. With respect to the time effect, no statistical change 
was detected between CON and PRE (-1.4 ± 36.5% (-57, 39%), p = 0.169, g = 0.090). 
Following the exercise protocol, Tvib decreased immediately POST (-13.2 ± 60.5% (-70, 23%), 
p = 0.035, g = 0.243) but recovered by 10 min (10.4 ± 44.3% (-47, 51%), p = 0.71, g = -0.016). 
 CONTROL PRE POST POST-10 POST-20 
Torque (Nm) N/A 249.4 ± 46.1 208.5 ± 41.2** 222.4 ± 42.4** 224.2 ± 45.3** 
SOL/M N/A 0.041 ± 0.016 0.038 ± 0.017 0.043 ± 0.020 0.043 ± 0.024 
MG/M N/A 0.040 ± 0.015 0.034 ± 0.011* 0.039 ± 0.013 0.041 ± 0.013 
TS/M N/A 0.079 ± 0.029 0.072 ± 0.022* 0.082 ± 0.026 0.084 ± 0.030 
TA (mV) N/A 0.095 ± 0.086 0.079 ± 0.061 0.083 ± 0.061 0.081 ± 0.062 
Tvib (Nm) 28.1 ± 28.0 30.7 ± 28.2 24.1 ± 25.3* 31.1 ± 28.6 29.5 ± 28.1 
Tsust (Nm) 27.9 ± 29.0 31.2 ± 28.5 22.6 ± 24.5* 31.0 ± 27.9 29.1 ± 28.5 
20 Hz (Nm) 94.1 ± 17.2 92.2 ± 16.6 78.4 ± 20.8** 78.3 ± 20.4** 76.2 ± 21.3** 
80 Hz (Nm) 124.1 ± 24.4 121.5 ± 24.1 103.6 ± 27.1** 106.9 ± 28.4** 105.4 ± 29.2** 
VFT (Nm) 95.8 ± 93.7* 93.7 ± 17.4 80.0 ± 21.0** 79.2 ± 21.1** 77.4 ± 21.8** 
20:80 Hz ratio 0.762 ± 0.052 0.763 ± 0.056 0.757 ± 0.057 0.735 ± 0.064 0.727 ± 0.063* 
20:VFT ratio 0.984 ± 0.025 0.985 ± 0.025 0.979 ± 0.023 0.993 ± 0.051 0.986 ± 0.032 
SOLBP Mmax mV) N/A 5.916 ± 2.704 4.744 ± 2.300** 4.577 ± 2.254* 4.749 ± 2.575* 
MG Mmax (mV) N/A 13.263 ± 3.547 12.303 ± 2.850 11.449 ± 2.815* 11.429 ± 2.666* 
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In Tsust, a significant main effect of time (F(4,16) = 2.559, p = 0.048) was detected (see 
Figure 3.7) but no condition (F(1,16) = 0.012, p = 0.916) or condition-by-time interaction effects 
(F(4,16) = 2.460, p = 0.055) were observed. With respect to the time effect, no statistical change 
was detected between CON and PRE (-1.8 ± 43.7% (-55, 34%), p = 0.169, g = 0.114). 
Following the exercise protocol, Tsust decreased immediately POST (-24.8 ± 53.6% (-69, 14%), 
p = 0.035, g = 0.322) but recovered by 10 min (8.4 ± 43.4% (-44, 43%), p = 0.71, g = 0.007). 
No correlations were observed between changes in reflexive torque variables and changes in 
torque. 
 
3.2.4 Tetanic evoked torque  
Torque produced during 20 Hz, 80 Hz and variable-frequency (VFT) trains as well as 
the 20:80 Hz ratio and 20:VFT ratio measured at CON, PRE, POST, POST-10 and POST-20 
are presented in Table 3.2. For torque in the 20-Hz train, a significant main effect of time 
(F(1.487,16) = 21.867, p < 0.001) was detected (see Figure 3.7) but no condition (F(1,16) = 2.975, 
p = 0.104) or condition-by-time interaction effects (F(2.123,16) = 0.175, p = 0.853) were observed. 
With respect to the time effect, no statistical change was detected between CON and PRE (2.3 
± 7.3% (-7, 11%), p = 0.065, g = 0.112). Following the exercise protocol, torque in the 20-Hz 
train decreased immediately POST (-15.3 ± 16.1% (-24, -5%), p < 0.001, g = 0.725) and did 
not recover by POST-10 (-15.1 ± 17.8% (-24, -5%), p < 0.001, g = 0.734) or POST-20 (-17.8 ± 
16.5% (-27, -7%), p < 0.001, g = 0.826) relative to PRE. 
For torque in the 80-Hz train, a significant main effect of time (F(1.653,16) = 24.756, p < 
0.001) was detected (see Figure 3.7) but no condition (F(1,16) = 1.973, p = 0.179) or condition-
by-time interaction effects (F(2.236,16) = 0.079, p = 0.940) were observed. With respect to the 
time effect, no statistical change was detected between CON and PRE (2.4 ± 6.8% (-7, 12%), 
p = 0.065, g = 0.108). Following the exercise protocol, torque in the 80-Hz train decreased 
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immediately POST (-15.3 ± 12.9% (-24, -4%), p < 0.001, g = 0.689) and did not recover by 
POST-10 (-12.4 ± 16.3% (-22, -2%), p < 0.001, g = 0.548) or POST-20 (-14 ± 15.7% (-23, -
3%), p < 0.001, g = 0.593). 
For torque in the VFT, a significant main effect of time (F(1.524,16) = 23.480, p < 0.001) 
was detected (see Figure 3.7) but no condition (F(1,16) = 3.230, p = 0.091) or condition-by-time 
interaction effects (F(2.120,16) = 0.125, p = 0.894) were observed. With respect to the time effect, 
a small but significant change was detected between CON and PRE (2.4 ± 7.2% (-7, 11%), p = 
0.046, g = 0.118). Following exercise, VFT torque decreased at POST (-14.9 ± 15.6% (-24, -
5%), p < 0.001, g = 0.701) and did not recover by POST-10 (-15.6 ± 17.8% (-25, -5%), p < 
0.001, g = 0.740) or POST-20 (-17.9 ± 16.5% (-27, -7%), p < 0.001, g = 0.815). 
Regarding the 20:80 Hz ratio, a significant main effect of time (F(2.242,16) = 4.313, p = 
0.018 was detected but no condition (F(1,16) = 0.113, p = 0.741) or condition-by-time interaction 
effects (F(2.502,16) = 0.377, p = 0.734) were observed. With respect to the time effect, no 
statistical difference was detected between time points except for POST-20 (-4.6 ± 7.1%, p < 
0.001, CI (-1, -2%), g = -0.043) relative to PRE. 
For the 20:VFT ratio, no significant time (F(2.315,16) = 0.662, p = 0.543), condition (F(1,16) 
= 0.1.262, p = 0.278) or condition-by-time interaction effects (F(2.884,16) = 0.554, p = 0.642) 
were observed. No correlations were observed between changes in tetanic torque variables and 
changes in torque. 
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Figure 3.7. Changes in torque, EMG, reflexive torque and tetanic torque measured from before to 
immediately (POST), 10 min (POST-10) and 20 min (POST-20) post-exercise. A) MVC torque, B) 
triceps surae EMG normalised to M-wave (TS/Mmax), C) mean torque after the 5th (last) stimulation 
during vibration (Tvib) and self-sustained torque (Tsust) measured 500 ms after vibration cessation, D) 
peak torque during 20-Hz, 80-Hz and VFT trains of electrical stimulation. *significantly different from 
PRE, p < 0.05. 
 
3.2.5 M-wave amplitude 
A significant main effect of time (F(3,16) = 8.975, p < 0.001) was detected in SOL Mmax, 
but no condition (F(1,16) = 0.121, p = 0.734) or condition-by-time interaction effects (F(3,16) = 
1.458, p = 0.240) were observed. With respect to the time effect, SOL Mmax decreased 
immediately POST (-15.1 ± 14.8%, p < 0.001, CI (-40, 1%), g = 0.458) and remained depressed 
at 10 min (-18.5 ± 16.1%, p = 0.001, CI (-43, -2%), g = 0.528) and 20 min (-18.2 ± 18.6%, p = 
0.003, CI (-41, 2%), g = 0.433). 
A significant main effect of time (F(1.505,16) = 10.379, p = 0.002) was detected in MG 
Mmax but no condition (F(1,16) = 1.657, p = 0.219) or condition-by-time interaction effects 
(F(2.139,16) = 1.402, p = 0.256) were observed. With respect to the time effect, no change in MG 
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Mmax was detected immediately POST (-3.8 ± 12.3%, p = 0.211, CI (-19, 5%), g = 0.295), 
however MG Mmax was depressed at 10 min (-12 ± 12.1%, p = 0.004, CI (-25, -2%), g = 0.560) 
and 20 min (-11.9 ± 11.8%, p = 0.002, CI (-25, -2%), g = 0.578) after exercise. 
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Discussion 
The primary aim of the present research was to examine the neuromuscular factors 
influencing the force loss and then recovery following repeated bouts of high-intensity, yet 
submaximal, muscular efforts. The thesis was divided into two experiments. The first 
experiment aimed to investigate the potential contribution of changes in corticospinal 
excitability to the decreases in neural drive and voluntary force following repeated, high-
intensity muscular efforts where fatigue was elicited in the human plantar flexors. The second 
experiment aimed to investigate whether inhibition of the MN facilitatory system or losses of 
muscle contractile capacity contributed to force decline. In both experiments, the isometric 
plantar flexion exercise induced a significant loss of peak isometric torque (12.2 ± 6.5% in 
Experiment 1 and 16.9 ± 7.3% in Experiment 2). The small difference in torque loss (p = 0.009) 
between experiments can be explained by: (1) in Experiment 1, six MVCs were performed and 
the average used for analysis whilst in Experiment 2 a single MVC was performed, and (2) the 
electrical stimulation techniques used to identify MN facilitation and muscle contractile 
capacity in Experiment 2 might have induced some additional fatigue or attenuated the 
recovery between the last repetition of the exercise protocol and the MVC. Regardless, the 
reduction in torque is consistent with previous studies where repeated submaximal muscular 
efforts resulted in a loss of torque (e.g. -43.3 ± 3.6% contracting at 50% MVC to failure in 
Neyroud et al. (2013), and -20.3 ± 12.0% at 75% MVC in Rozand, Cattagni, Theurel, Martin, 
and Lepers (2015)). 
The torque decreases were accompanied by reductions in the M-wave normalised EMG 
(EMG/M) immediately after exercise, which is indicative of a decrease in central/neural drive 
(Kalmar & Cafarelli, 2004b). However, the lack of significant correlation between the changes 
in these variables suggests that other factors play a larger role in the fatigue response. The 
simultaneous reduction in EMG/M and voluntary peak torque following high-intensity 
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muscular efforts are congruent with the findings of several other studies (Husmann et al., 2017; 
Kalmar et al., 2006; Place, Maffiuletti, Martin, & Lepers, 2007; Søgaard, Gandevia, Todd, 
Petersen, & Taylor, 2006) and suggests that impaired voluntary muscular force production after 
an acute bout of high-intensity exercise results in part from a reduction in neural drive. 
The mechanisms underlying this decrease in neural drive after repeated bouts of high-
intensity, yet submaximal, muscular contractions are unknown, although they are thought to 
include changes in descending input to the MNs (Taylor, Butler, et al., 2000). In the present 
study, MEP/M measured in the relaxed muscle was unchanged by the exercise protocol. When 
measured at rest, the MEP amplitude is believed to represent the balance between excitation 
and inhibition in the corticospinal-motoneuronal pathway, which can be modulated by 
sensory/afferent feedback (Chen, 2004). A reduction in MEP size following exercise might be 
explained by a reduction in cortical excitability, an increase in sensory inhibitory feedback to 
the MN (Taylor et al., 2016), and reductions in MN intrinsic properties (Heckman & Enoka, 
2012b). Nonetheless, as no change in the resting MEP/M at rest was detected in the present 
study, it could suggest there were no detectable changes in each of these sites in the absence of 
facilitatory voluntary drive, or different sites may have responded differently, resulting in a 
lack of overall change in MEP.  
MEP/M measured during MVC was found to decrease following high-intensity 
exercise and then recover by 10 min. This time course was consistent with the time course of 
change in EMG/M, which also recovered by 10 min, indicating a possible association between 
the two variables. This result is not consistent with previous findings in plantar flexor muscles, 
where MEP amplitude has been shown to increase (Hoffman et al., 2009) during submaximal 
sustained contractions or remain unchanged when assessed during a MVC after 45 intermittent 
maximal contractions (Iguchi & Shields, 2012). This finding is also observed in other muscle 
groups where MEPs has been shown to increase (Keller et al., 2011; Taylor, Allen, Butler, & 
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Gandevia, 2000) or remain unchanged (Fernandez‐del‐Olmo et al., 2013; Girard, Bishop, & 
Racinais, 2013; Goodall et al., 2015; Sidhu, Bentley, & Carroll, 2009; Yoon, Schlinder-Delap, 
Keller, & Hunter, 2011). The disparity between studies likely results from the high variability 
when utilising TMS techniques (Wassermann, 2002) as well as the testing and analysis methods 
used. It is interesting to note that it has been suggested that changes in MEP amplitude after 
fatiguing contractions could be dependent on the stimulation intensity used to evoke MEPs 
(Bachasson et al., 2016). In addition, differences in the fatiguing interventions (i.e. sustained 
or intermittent contractions, voluntary force level, contraction duration etc.) performed 
between studies is likely to influence the result. Finally, sample size is also likely to play a role 
in the statistical analysis of TMS variables, which was evident in Experiment 1 where 
significant changes in MEP amplitude and MEP/M were observed from PRE to POST when 
data were collapsed across conditions (CAF and NON-CAF) but not when each condition was 
examined separately (and sample size was thus reduced). Therefore, some caution is required 
when interpreting the results of the current study even though 16 participants were used. 
Regardless, the temporal alignment of changes in EMG/M and MEP/M amplitude provides 
reasonable evidence that a change in corticospinal excitability might be partly responsible for 
the loss in neural drive following high-intensity, submaximal exercise. It should be noted that 
the MEP amplitude itself was depressed throughout the recovery phase (i.e. to at least 20 min), 
however this coincided with an M-wave amplitude depression so MEP/M was observed to 
recover. This demonstrates the importance of accounting for possible peripheral changes at the 
muscle when assessing MEP changes; it certainly provides a better indicator of changes in 
corticospinal excitability following fatiguing exercise. 
Whilst the single-pulse TMS methods used in this study were sufficient to detect 
changes in corticospinal excitability, this technique only provided an indication of global 
changes within the whole corticospinal pathway. In order to differentiate between cortical and 
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spinal sites the use of paired TMS and cervicomedullary or thoracic electrical stimulation 
techniques may be required. The thoracic motor evoked potential (TMEP) protocol was tested 
for use in the current study, however it proved difficult to obtain reliable TMEPs in the plantar 
flexors.  
Of interest, the cortical silent period (cSP), considered to reflect changes in spinal and 
intracortical inhibitory mechanisms mediated by long-lasting gamma-aminobutyric acid 
(GABA)B receptors (Chen et al., 1999; Gruet et al., 2013; Taylor et al., 1996; Werhahn, 
Kunesch, Noachtar, Benecke, & Classen, 1999), was reduced following the exercise protocol 
and did not recover over the 20-min post-exercise period. Contrary to our findings, previous 
studies have typically reported increases in cSP duration after performance of sustained or 
intermittent low-intensity contractions (Gruet et al., 2014; Yoon et al., 2011) and maximal 
contractions (Goodall, Howatson, & Thomas, 2017; Taylor et al., 1996; Vernillo, Temesi, 
Martin, & Millet, 2017). This increase in cSP duration is believed to arise from an increase in 
fatigue-related (e.g. group III/IV) afferents (Hilty et al., 2011; Sidhu et al., 2017). Nonetheless, 
others have observed either no change (Goodall et al., 2015; Jubeau et al., 2017) or decreases 
in cSP after fatiguing exercise (Girard et al., 2013). Possible explanations for the discrepant 
findings include differences in exercise intensity, duration and recovery, as well as 
methodological testing procedures used. Of particular relevance is that intermittent 
contractions, where a short rest period was afforded between repetitions, were performed in the 
present study. This may have resulted in less group III/IV inhibitory afferent activity compared 
to a sustained effort where no rest is afforded throughout the effort. It is believed that the 
reduction in intracortical inhibition results from repetitive activation of somatosensory input to 
the primary motor cortex, thus increasing neural drive to the MN pool (Kidgell, Bonanno, 
Frazer, Howatson, & Pearce, 2017). It might be the case that the cSP reduction in the present 
study attenuated some of the loss in corticospinal excitability (which could possibly be due to 
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a reduction in MN excitability), although this was insufficient to prevent the loss of neural 
drive, as estimated through the EMG/M ratio. However, whether changes in sensory input are 
able to modify the cSP response after a single exercise session remains to be elucidated. If this 
were the case, then it might be that whilst some afferent input to the primary motor cortex 
improves neural drive to the MN, an excess of input might inhibit drive, and that the type of 
training performed is an influential factor. 
In addition to the loss in corticospinal excitability, MN disfacilitation is also a possible 
mechanism contributing to the loss of neural drive (Hultborn et al., 2003; Taylor, Butler, et al., 
2000). Alpha-MNs are strongly dependent upon facilitatory inputs to achieve a maximal 
discharge frequency, and thus to produce high levels of muscular force (Hultborn et al., 2003). 
This facilitatory modulation occurs at the motor neurone dendrites and is controlled by the 
interaction between descending monoaminergic drive and spinal circuits, especially including 
the Ia afferents (Heckman et al., 2005). It is well known that MNs rely on a PIC-mediated 
facilitatory system that increases synaptic gain in order to achieve maximal discharge 
frequency and thus to produce maximal levels of muscular force (Heckman et al., 2005; 
Hultborn et al., 2003). To test whether a loss in PIC-mediated facilitation of the MN occurs 
following fatigue, a combined vibration-electrical stimulation (VIB+STIM) protocol was used. 
The VIB+STIM technique is believed to reflect PIC activation because the responses to it 
display many of the hallmarks of PIC-dependent change, such as muscle length dependence, 
where reflexive torque increases as the muscle is lengthened (i.e. the antagonist is shortened), 
there is a wind-up effect during repeated muscle stimulations, and a self-sustained torque phase 
is notable after vibration cessation (Trajano et al., 2014). Our results showed reductions in 
reflexive torque (Tvib) production during vibration as well as reductions in the ability to sustain 
the torque without synaptic input (self-sustained torque; Tsust) following the exercise. These 
results are considered to indicate an impairment in PIC activation. Tvib and Tsust were 
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statistically recovered by 10 min, suggesting that the effects of the fatiguing exercise were 
overcome relatively quickly. This temporal profile is consistent with the change in EMG/M 
observed in both experiments 1 and 2, indicating the possibility of an association between the 
changes. Although the correlations between changes in EMG/M and Tvib and Tsust were not 
significant, this may reflect the time taken to measure the PIC amplitude (33 s), during which 
some level of recovery might have occurred, and the effects of measurement variability on 
correlation magnitude. Regardless, the present study is the first to provide evidence for the 
inhibitory effect of fatiguing exercise on spinal MN facilitatory systems.  
Both MEP amplitude and PIC amplification appeared to be depressed at POST but 
recovered by 10 min. This aligns temporally with the loss and recovery of EMG/M and strongly 
suggests that the current fatiguing exercise protocol was sufficient to reduce neural drive during 
an MVC completed immediately after the exercise, but that these changes recovered within 10 
min. These changes therefore cannot completely explain the prolonged loss of force that was 
observed at 20 min post-exercise. Therefore, other factors must be considered. 
Reductions in tetanic torque were evident in 20 Hz, 80 Hz and VFT tetanic stimulation 
conditions, suggesting that the muscle’s contractile capacity was compromised. However, the 
loss of force was similar across stimulation conditions and we were therefore unable to 
ascertain a specific process within the muscle that was predominant in the force decline. 
Previous studies have identified significant reductions in the 20:80 Hz ratio following fatiguing 
exercise such as downhill running (Martin et al., 2004) and concentric leg extension/flexion 
tasks (Hill, Thompson, Ruell, Thom, & White, 2001) and this is believed to be caused by a 
reduced Ca2+ release or faster uptake of Ca2+ into the sarcoplasmic reticulum (Binder‐Macleod 
& Kesar, 2005; MacIntosh & Rassier, 2002). However, the lack of relative differences in the 
torque change between the 20 Hz and 80 Hz trains in our experiment indicates a minimal effect 
of these mechanisms, which may have been due to the position of the ankle (0°) and the type 
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of muscle action (isometric) performed (Jones, 1996; Keeton & Binder-Macleod, 2006; Martin 
et al., 2004). The 20:VFT ratio is believed to represent changes in the muscle’s sensitivity to 
Ca2+, i.e. the ratio between the muscle’s myoplasmic Ca2+ concentration and the muscle’s force 
level. The lack of change in 20:VFT indicates that decreased Ca2+ sensitivity was not an 
overriding factor affecting force production following the fatiguing exercise. It is important to 
note, however, that because of the large compliance in the plantar flexors due to the long 
Achilles tendon the effect of the doublet stimulation on force production may be minimised 
when compared to other muscle groups such as the leg extensors (Binder‐Macleod & Kesar, 
2005) and this may have reduced our ability to detect small potential changes in the 20:VFT 
ratio. On the contrary, it might be the case that the doublet has a minimal effect in the plantar 
flexors and therefore a loss of the ability to use it, i.e. changes in Ca2+ sensitivity, may not be 
important. Alternatively, a loss of force per cross-bridge (Edman & Lou, 1990; MacIntosh & 
Rassier, 2002), reduced force transmission from the contractile elements to the bone, or the 
cumulative effect of small (difficult to detect) changes in multiple force generating processes 
may have underpinned the force decline. More research is needed to explicitly locate the 
mechanism/s, however the data strongly suggest that interventions that allow maintenance of 
muscular force production will help to reduce the force decline after high-intensity, repetitive 
muscular contractions, or at least increase the rate of recovery.  
M-wave amplitudes were depressed following the fatigue exercise protocol and did not 
recover within the 20-min recovery period in both experiments; thus, M-wave depression was 
temporally associated with the loss of voluntary force. M-wave amplitude is considered to 
provide information relating to the ability of the sarcolemma to transmit excitatory potentials 
to the calcium release channels (Green, 2004; Rodriguez‐Falces & Place, 2016), although 
interpretation of M-wave changes is complex due to the M-wave being highly sensitive to 
positional changes of the recording electrodes relative to the muscle-tendon complex 
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(Rodriguez-Falces & Place, 2014) as well as the changes in muscle geometry (pennation angle 
and fascicle length) that may occur during fatiguing exercise (Hodges, Pengel, Herbert, & 
Gandevia, 2003; Narici et al., 1996). Nonetheless, the repeatable findings (in Experiments 1 
and 2) of M-wave depression indicates that a change in fibre membrane excitability may have 
occurred and could have contributed to the prolonged loss of force following the exercise. 
However, evidence against a physiological effect of the M-wave amplitude reduction in the 
current study comes from the lack of change in the 20:80 Hz ratio. If the 20:80 Hz ratio is 
sensitive enough to reflect changes in Ca2+ release from the Ca2+ release channels, then the lack 
of change in the current study suggests that possible reductions in sarcolemmal excitability 
were insufficient to meaningfully impede muscle Ca2+ release and thus muscle function. Future 
research might more explicitly examine the different phases of the M-wave, as each are 
believed to represent different characteristics in membrane excitability (Rodriguez-Falces & 
Place, 2017; Rodriguez‐Falces & Place, 2016). This may provide further evidence as to the 
mechanisms influencing the M wave, specifically whether the changes in M-wave amplitude 
result from changes in membrane excitability (possibly due to the rise in extracellular K+) or 
changes in muscle-tendon architectural features, as is more likely in the current study due to 
the lack of change in the 20:80 Hz ratio (Rodriguez‐Falces & Place, 2016). 
The second main purpose of the present study was to determine whether caffeine might 
reduce the fatiguing effect of the exercise. The results showed that the prior consumption of 
caffeine resulted in a robust increase in muscle force production and neural drive (EMG/M) 
measured during MVC across the points. (i.e. there was an effect of condition). This allowed 
for greater MVC force to be produced in the recovery from exercise, with statistical differences 
from the NON-CAF condition being observed at 10 and 20 min after the fatiguing bout in 
Experiment 1 as well as before and 20 min after the fatiguing bout in Experiment 2. 
Nonetheless, no condition-by-time interaction was observed, suggesting that caffeine did not 
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affect force production at any specific time point, i.e. before or in recovery from exercise. 
Therefore, caffeine was not observed to minimise the loss of force evoked by exercise. The 
greater force production in the caffeine condition was associated with an increase in neural 
drive, as estimated using the EMG/M ratio. This finding is consistent with evidence that 
caffeine exerts the majority of its effects on the nervous system (Fredholm, Bättig, Holmén, 
Nehlig, & Zvartau, 1999; Snyder, Katims, Annau, Bruns, & Daly, 1981; Tallis, James, Cox, & 
Duncan, 2012). The mechanisms of caffeine on the nervous system are multifaceted, and 
include adenosine antagonistic behaviour, which theoretically should increase MEP amplitude 
(Gandevia & Taylor, 2006; Kalmar & Cafarelli, 2004a), as well as the upregulation in 
noradrenergic and serotonergic drive, which could potentially increase PIC activation 
(Heckman et al., 2008) and thus improve excitability at the somato-dendritic end of the MN 
(Cotel et al., 2013). However, corticospinal excitability (MEP) and MN facilitation (sustained 
torque; Tsust) were not statistically affected by the ingestion of caffeine, thus it is likely that 
caffeine had no discernible effect on MN pre- or post-somatic sites and that caffeine exerted its 
effects on neural mechanisms not tested within the present study, or that our tests were not 
sensitive enough to detect differences in corticospinal excitability and MN facilitation between 
the non-caffeine and caffeine conditions. 
Caffeine may also exert effects peripherally via alterations in intramuscular ion 
handling, such as increased Ca2+ mobilisation from the sarcoplasmic reticulum, and this may 
produce favourable effects on E-C coupling (Davis & Green, 2009; Magkos & Kavouras, 
2005). However, no differences were detected in evoked torque (20 Hz, 80 Hz or VFTs) 
between the caffeine and non-caffeine conditions at any time point, which suggests that 
caffeine ingestion did not have a discernible effect on E-C coupling either before or after the 
high-intensity intermittent exercise. Therefore, it is likely that the ergogenic benefits of caffeine 
were confined to the nervous system. 
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It should be noted that an individual variability in the responsiveness to caffeine was 
detected between participants. On average, caffeine improved MVC torque production by >3% 
in approximately half (53%) of the participants across both experiments, whilst in 9% of 
participants the torque production was reduced; no effect was observed (the changes were ± 
3%) in the remaining 38% of participants. Therefore, caffeine may have some effect on the 
neuromuscular function in some participants, suggesting that individual responses to caffeine 
need to be determined in order to decide whether an ergogenic effect is evoked before and/or 
after the performance of sets of high-intensity, fatiguing muscular efforts. It is also of note that 
the dosage of 3 mg·kg-1 body mass used in the present study is lower than that used in previous 
research (Behrens et al., 2015; Davis & Green, 2009; Walton et al., 2003; Walton et al., 2002), 
where doses of 6 mg·kg-1 body mass are used. The lower dose was chosen to better represent 
the dosages that might commonly be ingested through the consumption of energy drinks, 
coffee, pre-workout supplements, etc. Utilising a caffeine dosage greater than 3 mg·kg-1 might 
potentially produce results different to those seen in the present study, although their ecological 
validity might be reduced. 
 
4.1 Conclusion 
The results of the present research indicate that the performance of repeated high-
intensity, but submaximal, muscular efforts results in a significant and prolonged (>20 min) 
loss of force which is likely to influence subsequent bouts of work. The loss of force was 
accompanied by a loss of neural drive measured during MVCs immediately after exercise, 
which were further accompanied by decreases in corticospinal excitability and MN facilitation. 
However, neural drive (and associated physiological changes) recovered quickly and cannot 
explain the ongoing loss of force, even if it contributed to the greater loss of force detected 
early in the recovery phase. Interestingly, cSP was shortened immediately after exercise and at 
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later points in the recovery and might act to partly compensate for the loss in corticospinal 
excitability, however more research is required to confirm this assertion. Whilst neural drive 
recovered by 10 min, significant decreases in tetanic torque were observed at later points in the 
recovery (i.e. 10 and 20 min), which might explain the prolonged loss of torque. However, no 
specific process within the muscle was predominant in the force decline, thus no conclusions 
can be drawn as to the muscular mechanism/s responsible for the loss of torque following 
repeated, high-intensity contractions. 
Caffeine improved muscle force production and neural drive (EMG/M) measured 
during MVC. However, its effects did not appear to affect corticospinal excitability or MN 
facilitation pathways, and it is likely that caffeine exerted its effects on neural mechanisms not 
tested within the present study, or that our tests were insufficient to detect small changes in 
corticospinal excitability and MN facilitation between the non-caffeine and caffeine conditions. 
 
4.2 Future directions  
The present experiments were conducted under controlled laboratory conditions 
involving single-joint isometric, muscle contractions, and it might be the case that different 
muscle groups respond differently to both the exercise and caffeine ingestion. For instance, 
compound multi-joint movements that require activation of numerous muscles in a skilled 
manner may require greater neural regulation and activation than isolated single-joint activities, 
and therefore might trigger greater changes in corticospinal and MN facilitatory processes. In 
addition, the ergogenic effects of caffeine might be exacerbated when greater neural drive is 
required, as is likely the case in compound multi-joint movements that involve activation of a 
larger total muscle mass. Finally, individual variations in responses to caffeine might also play 
a role, and thus should be considered when using caffeine as an ergogenic aid. Regarding 
peripheral changes, the prolonged loss of muscular force following repeated high-intensity 
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submaximal efforts appeared to be attributable to changes within the muscle itself. Thus, future 
work might investigate the precise mechanisms responsible for the long-lasting loss of force 
so that training interventions and both nutrition and supplement strategies can be developed to 
target those mechanisms and thus reduce recovery time following repetitive high-intensity 
efforts. 
 
66 
 
References 
Allen, D. (2004). Skeletal muscle function: role of ionic changes in fatigue, damage and 
disease. Clinical and Experimental Pharmacology and Physiology, 31(8), 485-493.  
Allen, D., Westerblad, H., Lee, J., & Lännergren, J. (1992). Role of excitation-contraction 
coupling in muscle fatigue. Sports Medicine, 13(2), 116-126.  
Allen, D. G. (2009). Fatigue in working muscles. Journal of Applied Physiology, 106(2), 358-
359.  
Allen, D. G., Lamb, G. D., & Westerblad, H. (2008). Skeletal muscle fatigue: cellular 
mechanisms. Physiological Reviews, 88(1), 287-332.  
Bachasson, D., Temesi, J., Gruet, M., Yokoyama, K., Rupp, T., Millet, G., & Verges, S. 
(2016). Transcranial magnetic stimulation intensity affects exercise-induced changes 
in corticomotoneuronal excitability and inhibition and voluntary activation. 
Neuroscience, 314, 125-133.  
Bakker, A. J., Cully, T. R., Wingate, C. D., Barclay, C. J., & Launikonis, B. S. (2017). 
Doublet stimulation increases Ca 2+ binding to troponin C to ensure rapid force 
development in skeletal muscle. The Journal of General Physiology, 149(3), 323-334.  
Balog, E. M. (2010). Excitation-contraction coupling and minor triadic proteins in low-
frequency fatigue. Exercise and Sport Sciences Reviews, 38(3), 135-142.  
Behrens, M., Mau-Moeller, A., Weippert, M., Fuhrmann, J., Wegner, K., Skripitz, R., . . . 
Bruhn, S. (2015). Caffeine-induced increase in voluntary activation and strength of 
the quadriceps muscle during isometric, concentric and eccentric contractions. 
Scientific Reports, 5.  
Bennett, D. J., Hultborn, H., Fedirchuk, B., & Gorassini, M. (1998). Synaptic activation of 
plateaus in hindlimb motoneurons of decerebrate cats. Journal of Neurophysiology, 
80(4), 2023-2037.  
Bentley, L., & Lehman, S. (2005). Doublets and low‐frequency fatigue in potentiated human 
muscle. Acta Physiologica Scandinavica, 185(1), 51-60.  
Bigland‐Ritchie, B., & Woods, J. (1984). Changes in muscle contractile properties and neural 
control during human muscular fatigue. Muscle & Nerve, 7(9), 691-699.  
Binder, M. D. (2003). Intrinsic dendritic currents make a major contribution to the control of 
motoneurone discharge. The Journal of Physiology, 552(3), 665-665.  
Binder-Macleod, S. A., & Barrish, W. J. (1992). Force response of rat soleus muscle to 
variable-frequency train stimulation. Journal of Neurophysiology, 68(4), 1068-1078.  
Binder-Macleod, S. A., & Russ, D. W. (1999). Effects of activation frequency and force on 
low-frequency fatigue in human skeletal muscle. Journal of Applied Physiology, 
86(4), 1337-1346.  
Binder‐Macleod, S., & Kesar, T. (2005). Catchlike property of skeletal muscle: recent 
findings and clinical implications. Muscle & nerve, 31(6), 681-693.  
Bompa, T. O., & Haff, G. G. (2009). Periodization: Theory and Methodology of Training 
(5th ed.). Champaign, IL: Human Kinetics. 
Burke, R., Rudomin, P., & Zajac, F. (1970). Catch property in single mammalian motor units. 
Science, 168(3927), 122-124.  
Burke, R., Rudomin, P., & Zajac, F. E. (1976). The effect of activation history on tension 
production by individual muscle units. Brain Research, 109(3), 515-529.  
Butler, J. E., Taylor, J. L., & Gandevia, S. C. (2003). Responses of human motoneurons to 
corticospinal stimulation during maximal voluntary contractions and ischemia. The 
Journal of Neuroscience, 23(32), 10224-10230.  
67 
 
Cannavan, D., Coleman, D. R., & Blazevich, A. J. (2012). Lack of effect of moderate-
duration static stretching on plantar flexor force production and series compliance. 
Clinical Biomechanics, 27(3), 306-312.  
Capaday, C. (1997). Neurophysiological methods for studies of the motor system in freely 
moving human subjects. Journal of Neuroscience Methods, 74(2), 201-218.  
Cappelletti, S., Daria, P., Sani, G., & Aromatario, M. (2015). Caffeine: Cognitive and 
Physical Performance Enhancer or Psychoactive Drug? Current Neuropharmacology, 
13(1), 71-88.  
Carlin, K., Jones, K., Jiang, Z., Jordan, L., & Brownstone, R. (2000). Dendritic L‐type 
calcium currents in mouse spinal motoneurons: implications for bistability. European 
Journal of Neuroscience, 12(5), 1635-1646.  
Chen, R. (2004). Interactions between inhibitory and excitatory circuits in the human motor 
cortex. Experimental Brain Research, 154(1), 1-10.  
Chen, R., Lozano, A. M., & Ashby, P. (1999). Mechanism of the silent period following 
transcranial magnetic stimulation evidence from epidural recordings. Experimental 
Brain Research, 128(4), 539-542.  
Cheng, A. J., Place, N., Bruton, J. D., Holmberg, H. C., & Westerblad, H. (2013). Doublet 
discharge stimulation increases sarcoplasmic reticulum Ca2+ release and improves 
performance during fatiguing contractions in mouse muscle fibres. The Journal of 
Physiology, 591(15), 3739-3748.  
Cotel, F., Exley, R., Cragg, S. J., & Perrier, J.-F. (2013). Serotonin spillover onto the axon 
initial segment of motoneurons induces central fatigue by inhibiting action potential 
initiation. Proceedings of the National Academy of Sciences, 110(12), 4774-4779.  
Crone, C., Hultborn, H., Kiehn, O., Mazieres, L., & Wigström, H. (1988). Maintained 
changes in motoneuronal excitability by short‐lasting synaptic inputs in the 
decerebrate cat. The Journal of Physiology, 405(1), 321-343.  
D’Amico, J. M., Butler, A. A., Héroux, M. E., Butler, J. E., Gandevia, S. C., & Taylor, J. L. ( 
2015). Activation of 5HT1A Receptors Inhibits Motoneurone Excitability in Humans. 
Paper presented at the Neuroscience Research Australia, Sydney, Australia.  
Damron, L. A., Dearth, D. J., Hoffman, R. L., & Clark, B. C. (2008). Quantification of the 
corticospinal silent period evoked via transcranial magnetic stimulation. Journal of 
Neuroscience Methods, 173(1), 121-128.  
Davis, J., & Green, J. M. (2009). Caffeine and anaerobic performance. Sports Medicine, 
39(10), 813-832.  
Debold, E. P. (2016). Decreased Myofilament Calcium Sensitivity Plays a Significant Role in 
Muscle Fatigue. Exercise and Sport Sciences Reviews, 44(4), 144-149.  
Debold, E. P., Dave, H., & Fitts, R. H. (2004). Fiber type and temperature dependence of 
inorganic phosphate: implications for fatigue. American Journal of Physiology-Cell 
Physiology, 287(3), C673-C681.  
Desmedt, J. E., & Godaux, E. (1978). Mechanism of the vibration paradox: excitatory and 
inhibitory effects of tendon vibration on single soleus muscle motor units in man. The 
Journal of Physiology, 285(1), 197-207.  
Di Lazzaro, V., Oliviero, A., Profice, P., Meglio, M., Cioni, B., Tonali, P., & Rothwell, J. 
(2001). Descending spinal cord volleys evoked by transcranial magnetic and electrical 
stimulation of the motor cortex leg area in conscious humans. The Journal of 
Physiology, 537(3), 1047-1058.  
Di Lazzaro, V., Rothwell, J., & Capogna, M. (2017). Noninvasive Stimulation of the Human 
Brain: Activation of Multiple Cortical Circuits. The Neuroscientist, 
1073858417717660.  
68 
 
Edman, K., & Lou, F. (1990). Changes in force and stiffness induced by fatigue and 
intracellular acidification in frog muscle fibres. The Journal of Physiology, 424(1), 
133-149.  
Edwards, R., Hill, D., Jones, D., & Merton, P. (1977). Fatigue of long duration in human 
skeletal muscle after exercise. The Journal of Physiology, 272(3), 769.  
Fernandez‐del‐Olmo, M., Rodriguez, F., Marquez, G., Iglesias, X., Marina, M., Benitez, A., . 
. . Acero, R. (2013). Isometric knee extensor fatigue following a Wingate test: 
peripheral and central mechanisms. Scandinavian Journal of Medicine & Science in 
Sports, 23(1), 57-65.  
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999). Actions of 
caffeine in the brain with special reference to factors that contribute to its widespread 
use. Pharmacological Reviews, 51(1), 83-133.  
Frigon, A., Thompson, C. K., Johnson, M. D., Manuel, M., Hornby, T. G., & Heckman, C. 
(2011). Extra forces evoked during electrical stimulation of the muscle or its nerve are 
generated and modulated by a length-dependent intrinsic property of muscle in 
humans and cats. The Journal of Neuroscience, 31(15), 5579-5588.  
Gandevia, S. (1998). Neural control in human muscle fatigue: changes in muscle afferents, 
moto neurones and moto cortical drive. Acta Physiologica Scandinavica, 162(3), 275-
283.  
Gandevia, S. (2001). Spinal and supraspinal factors in human muscle fatigue. Physiological 
Reviews, 81(4), 1725-1789.  
Gandevia, S., Allen, G. M., Butler, J. E., & Taylor, J. L. (1996). Supraspinal factors in human 
muscle fatigue: evidence for suboptimal output from the motor cortex. The Journal of 
Physiology, 490(2), 529-536.  
Gandevia, S., Petersen, N., Butler, J., & Taylor, J. (1999). Impaired response of human 
motoneurones to corticospinal stimulation after voluntary exercise. The Journal of 
Physiology, 521(3), 749-759.  
Gandevia, S., & Taylor, J. (2006). Supraspinal fatigue: the effects of caffeine on human 
muscle performance. Journal of Applied Physiology, 100(6), 1749-1750.  
Garland, S. J., & Griffin, L. (1999). Motor unit double discharges: statistical anomaly or 
functional entity? Canadian Journal of Applied Physiology, 24(2), 113-130.  
Girard, O., Bishop, D. J., & Racinais, S. (2013). Neuromuscular adjustments of the 
quadriceps muscle after repeated cycling sprints. PloS one, 8(5), e61793.  
Goodall, S., Charlton, K., Howatson, G., & Thomas, K. (2015). Neuromuscular fatigability 
during repeated-sprint exercise in male athletes. Medicine & Science in Sports & 
Exercise, 47(3), 528-536.  
Goodall, S., Howatson, G., & Thomas, K. (2017). Modulation of specific inhibitory networks 
in fatigued locomotor muscles of healthy males. Experimental Brain Research, 1-11.  
Gorassini, M. A., Bennett, D. J., & Yang, J. F. (1998). Self-sustained firing of human motor 
units. Neuroscience Letters, 247(1), 13-16.  
Graham, T. E., Rush, J. W., & Soeren, M. H. v. (1994). Caffeine and exercise: metabolism 
and performance. Canadian Journal of Applied Physiology, 19(2), 111-138.  
Green, H. J. (2004). Membrane excitability, weakness, and fatigue. Canadian Journal of 
Applied Physiology, 29(3), 291-307.  
Griffin, L., Garland, S., & Ivanova, T. (1998). Discharge patterns in human motor units 
during fatiguing arm movements. Journal of Applied Physiology, 85(5), 1684-1692.  
Gruet, M., Temesi, J., Rupp, T., Levy, P., Millet, G., & Verges, S. (2013). Stimulation of the 
motor cortex and corticospinal tract to assess human muscle fatigue. Neuroscience, 
231, 384-399.  
69 
 
Gruet, M., Temesi, J., Rupp, T., Levy, P., Verges, S., & Millet, G. Y. (2014). Dynamics of 
corticospinal changes during and after high‐intensity quadriceps exercise. 
Experimental Physiology, 99(8), 1053-1064.  
Hallett, M. (2000). Transcranial magnetic stimulation and the human brain. Nature, 
406(6792), 147-150.  
Heckman, C., & Binder, M. D. (1988). Analysis of effective synaptic currents generated by 
homonymous Ia afferent fibers in motoneurons of the cat. Journal of 
Neurophysiology, 60(6), 1946-1966.  
Heckman, C., & Enoka, R. M. (2012a). Motor unit. Comprehensive Physiology, 2(4), 2629-
2682.  
Heckman, C., & Enoka, R. M. (2012b). Motor unit. Comprehensive Physiology.  
Heckman, C., Gorassini, M. A., & Bennett, D. J. (2005). Persistent inward currents in 
motoneuron dendrites: implications for motor output. Muscle & Nerve, 31(2), 135-
156.  
Heckman, C., Johnson, M., Mottram, C., & Schuster, J. (2008). Persistent inward currents in 
spinal motoneurons and their influence on human motoneuron firing patterns. The 
Neuroscientist, 14(3), 264.  
Heckman, C., Lee, R. H., & Brownstone, R. M. (2003). Hyperexcitable dendrites in 
motoneurons and their neuromodulatory control during motor behavior. Trends in 
Neurosciences, 26(12), 688-695.  
Henneman, E. (1985). The size-principle: a deterministic output emerges from a set of 
probabilistic connections. Journal of Experimental Biology, 115(1), 105-112.  
Hill, C. A., Thompson, M. W., Ruell, P. A., Thom, J. M., & White, M. J. (2001). 
Sarcoplasmic reticulum function and muscle contractile character following fatiguing 
exercise in humans. The Journal of Physiology, 531(3), 871-878.  
Hilty, L., Lutz, K., Maurer, K., Rodenkirch, T., Spengler, C. M., Boutellier, U., . . . Amann, 
M. (2011). Spinal opioid receptor‐sensitive muscle afferents contribute to the fatigue‐
induced increase in intracortical inhibition in healthy humans. Experimental 
Physiology, 96(5), 505-517.  
Hodges, P., Pengel, L., Herbert, R., & Gandevia, S. (2003). Measurement of muscle 
contraction with ultrasound imaging. Muscle & Nerve, 27(6), 682-692.  
Hoffman, B. W., Oya, T., Carroll, T. J., & Cresswell, A. G. (2009). Increases in corticospinal 
responsiveness during a sustained submaximal plantar flexion. Journal of Applied 
Physiology, 107(1), 112-120.  
Hounsgaard, J., Hultborn, H., Jespersen, B., & Kiehn, O. (1988). Bistability of alpha‐
motoneurones in the decerebrate cat and in the acute spinal cat after intravenous 5‐
hydroxytryptophan. The Journal of Physiology, 405(1), 345-367.  
Hounsgaard, J., & Kiehn, O. (1993). Calcium spikes and calcium plateaux evoked by 
differential polarization in dendrites of turtle motoneurones in vitro. The Journal of 
Physiology, 468(1), 245-259.  
Hultborn, H., Denton, M. E., Wienecke, J., & Nielsen, J. B. (2003). Variable amplification of 
synaptic input to cat spinal motoneurones by dendritic persistent inward current. The 
Journal of Physiology, 552(3), 945-952.  
Husmann, F., Gube, M., Felser, S., Weippert, M., Mau-Moeller, A., Bruhn, S., & Behrens, M. 
(2017). Central Factors Contribute to Knee Extensor Strength Loss after 2000-m 
Rowing in Elite Male and Female Rowers. Medicine and Science in Sports and 
Exercise, 49(3), 440-449.  
Iguchi, M., & Shields, R. K. (2012). Cortical and segmental excitability during fatiguing 
contractions of the soleus muscle in humans. Clinical Neurophysiology, 123(2), 335-
343.  
70 
 
Jones, D. (1996). High‐and low‐frequency fatigue revisited. Acta Physiologica, 156(3), 265-
270.  
Jubeau, M., Rupp, T., Temesi, J., Perrey, S., Wuyam, B., Millet, G. Y., & Verges, S. (2017). 
Neuromuscular Fatigue during Prolonged Exercise in Hypoxia. Medicine and Science 
in Sports and Exercise, 49(3), 430-439.  
Kalmar, J., Del Balso, C., & Cafarelli, E. (2006). Increased spinal excitability does not offset 
central activation failure. Experimental Brain Research, 173(3), 446-457.  
Kalmar, J. M., & Cafarelli, E. (2004a). Caffeine: a valuable tool to study central fatigue in 
humans? Exercise and Sport Sciences Reviews, 32(4), 143-147.  
Kalmar, J. M., & Cafarelli, E. (2004b). Central fatigue and transcranial magnetic stimulation: 
effect of caffeine and the confound of peripheral transmission failure. Journal of 
Neuroscience Methods, 138(1), 15-26.  
Kamen, G., Sullivan, R., Rubinstein, S., & Christie, A. (2006). Evidence of self-sustained 
motoneuron firing in young and older adults. Journal of Electromyography and 
Kinesiology, 16(1), 25-31.  
Kaneko, K., Kawai, S., Fuchigami, Y., Shiraishi, G., & Ito, T. (1996). Effect of stimulus 
intensity and voluntary contraction on corticospinal potentials following transcranial 
magnetic stimulation. Journal of the Neurological Sciences, 139(1), 131-136.  
Keeton, R. B., & Binder-Macleod, S. A. (2006). Low-frequency fatigue. Physical Therapy, 
86(8), 1146.  
Keller, M. L., Pruse, J., Yoon, T., Schlinder-Delap, B., Harkins, A., & Hunter, S. K. (2011). 
Supraspinal fatigue is similar in men and women for a low-force fatiguing 
contraction. Medicine and Science in Sports and Exercise, 43(10), 1873-1883.  
Khan, S. I., Giesebrecht, S., Gandevia, S. C., & Taylor, J. L. (2012). Activity‐dependent 
depression of the recurrent discharge of human motoneurones after maximal 
voluntary contractions. The Journal of Physiology, 590(19), 4957-4969.  
Kidgell, D. J., Bonanno, D. R., Frazer, A. K., Howatson, G., & Pearce, A. J. (2017). 
Corticospinal responses following strength training: a systematic review and meta‐
analysis. European Journal of Neuroscience.  
Kiehn, O., & Eken, T. (1997). Prolonged firing in motor units: evidence of plateau potentials 
in human motoneurons? Journal of Neurophysiology, 78(6), 3061-3068.  
Knuth, S. T., Dave, H., Peters, J. R., & Fitts, R. (2006). Low cell pH depresses peak power in 
rat skeletal muscle fibres at both 30 C and 15 C: implications for muscle fatigue. The 
Journal of Physiology, 575(3), 887-899.  
Lamb, G. (2000). Excitation–contraction coupling in skeletal muscle: comparisons with 
cardiac muscle. Clinical and Experimental Pharmacology and Physiology, 27(3), 
216-224.  
Lamb, G. D. (2002). Excitation–contraction coupling and fatigue mechanisms in skeletal 
muscle: studies with mechanically skinned fibres. Journal of Muscle Research and 
Cell Motility, 23(1), 81-91.  
Lee, R., & Heckman, C. (1996). Influence of voltage-sensitive dendritic conductances on 
bistable firing and effective synaptic current in cat spinal motoneurons in vivo. 
Journal of Neurophysiology, 76(3), 2107-2110.  
Lee, R., & Heckman, C. (1999). Paradoxical effect of QX-314 on persistent inward currents 
and bistable behavior in spinal motoneurons in vivo. Journal of Neurophysiology, 
82(5), 2518-2527.  
Lee, R., Kuo, J., Jiang, M., & Heckman, C. (2003). Influence of active dendritic currents on 
input-output processing in spinal motoneurons in vivo. Journal of Neurophysiology, 
89(1), 27-39.  
71 
 
Liu, C. j., & Latham, N. K. (2009). Progressive resistance strength training for improving 
physical function in older adults. The Cochrane Library.  
Macefield, G., Hagbarth, K.-E., Gorman, R., Gandevia, S., & Burke, D. (1991). Decline in 
spindle support to alpha‐motoneurones during sustained voluntary contractions. The 
Journal of Physiology, 440(1), 497-512.  
MacIntosh, B. R., & Rassier, D. E. (2002). What is fatigue? Canadian Journal of Applied 
Physiology, 27(1), 42-55.  
Mademli, L., & Arampatzis, A. (2005). Behaviour of the human gastrocnemius muscle 
architecture during submaximal isometric fatigue. European Journal of Applied 
Physiology, 94(5-6), 611-617.  
Maffiuletti, N. A., Aagaard, P., Blazevich, A. J., Folland, J., Tillin, N., & Duchateau, J. 
(2016). Rate of force development: physiological and methodological considerations. 
European Journal of Applied Physiology, 116(6), 1091-1116.  
Magalhães, F. H., de Toledo, D. R., & Kohn, A. F. (2013). Plantar flexion force induced by 
amplitude-modulated tendon vibration and associated soleus V/F-waves as an 
evidence of a centrally-mediated mechanism contributing to extra torque generation in 
humans. Journal of Neuroengineering and Rehabilitation, 10(1), 32.  
Magalhães, F. H., & Kohn, A. F. (2010). Research vibration-induced extra torque during 
electrically-evoked contractions of the human calf muscles. Journal of 
Neuroengineering and Rehabilitation, 7(1), 26.  
Magkos, F., & Kavouras, S. A. (2005). Caffeine use in sports, pharmacokinetics in man, and 
cellular mechanisms of action. Critical Reviews in Food Science and Nutrition, 45(7-
8), 535-562.  
Martin, P. G., Gandevia, S. C., & Taylor, J. L. (2006). Output of human motoneuron pools to 
corticospinal inputs during voluntary contractions. Journal of Neurophysiology, 95(6), 
3512-3518.  
Martin, V., Millet, G. Y., Martin, A., Deley, G., & Lattier, G. (2004). Assessment of low-
frequency fatigue with two methods of electrical stimulation. Journal of Applied 
Physiology, 97(5), 1923-1929.  
McDonnell, M. N., Orekhov, Y., & Ziemann, U. (2006). The role of GABAB receptors in 
intracortical inhibition in the human motor cortex. Experimental Brain Research, 
173(1), 86-93.  
McKenna, M. J., Bangsbo, J., & Renaud, J.-M. (2008). Muscle K+, Na+, and Cl− 
disturbances and Na+-K+ pump inactivation: implications for fatigue. Journal of 
Applied Physiology, 104(1), 288-295.  
McNeil, C. J., Butler, J. E., Taylor, J. L., & Gandevia, S. C. (2013). Testing the excitability of 
human motoneurons. Frontiers in Human Neuroscience, 7, 152.  
McNeil, C. J., Giesebrecht, S., Gandevia, S. C., & Taylor, J. L. (2011). Behaviour of the 
motoneurone pool in a fatiguing submaximal contraction. The Journal of Physiology, 
589(14), 3533-3544.  
McNeil, C. J., Giesebrecht, S., Khan, S. I., Gandevia, S. C., & Taylor, J. L. (2011). The 
reduction in human motoneurone responsiveness during muscle fatigue is not 
prevented by increased muscle spindle discharge. The Journal of Physiology, 589(15), 
3731-3738.  
McNeil, C. J., Martin, P. G., Gandevia, S. C., & Taylor, J. L. (2009). The response to paired 
motor cortical stimuli is abolished at a spinal level during human muscle fatigue. The 
Journal of Physiology, 587(23), 5601-5612.  
McPherson, J. G., Ellis, M. D., Heckman, C., & Dewald, J. P. (2008). Evidence for increased 
activation of persistent inward currents in individuals with chronic hemiparetic stroke. 
Journal of Neurophysiology, 100(6), 3236-3243.  
72 
 
Moss, R. L., Lynch, T. L., & Fitzsimons, D. P. (2017). Acting on an impulse (or two): 
Advantages of high-frequency tetanic onset in skeletal muscle. The Journal of 
General Physiology, jgp. 201711763.  
Mottram, C. J., Suresh, N. L., Heckman, C., Gorassini, M. A., & Rymer, W. Z. (2009). 
Origins of abnormal excitability in biceps brachii motoneurons of spastic-paretic 
stroke survivors. Journal of Neurophysiology, 102(4), 2026-2038.  
Narici, M. V., Binzoni, T., Hiltbrand, E., Fasel, J., Terrier, F., & Cerretelli, P. (1996). In vivo 
human gastrocnemius architecture with changing joint angle at rest and during graded 
isometric contraction. The Journal of Physiology, 496(1), 287-297.  
Nehlig, A., Daval, J.-L., & Debry, G. (1992). Caffeine and the central nervous system: 
mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain 
Research Reviews, 17(2), 139-170.  
Nelson, C. R., Debold, E. P., & Fitts, R. H. (2014). Phosphate and acidosis act synergistically 
to depress peak power in rat muscle fibers. American Journal of Physiology-Cell 
Physiology, 307(10), C939-C950.  
Neyroud, D., Rüttimann, J., Mannion, A. F., Millet, G. Y., Maffiuletti, N. A., Kayser, B., & 
Place, N. (2013). Comparison of neuromuscular adjustments associated with sustained 
isometric contractions of four different muscle groups. Journal of Applied Physiology, 
114(10), 1426-1434.  
Nielsen, B. G. (2009). Calcium and the role of motoneuronal doublets in skeletal muscle 
control. European Biophysics Journal, 38(2), 159-173.  
Nielsen, J., & Petersen, N. (1995). Changes in the effect of magnetic brain stimulation 
accompanying voluntary dynamic contraction in man. The Journal of physiology, 
484(3), 777-789.  
Nielsen, J. B. (2004). Sensorimotor integration at spinal level as a basis for muscle 
coordination during voluntary movement in humans. Journal of Applied Physiology, 
96(5), 1961-1967.  
Nijs, J., Daenen, L., Cras, P., Struyf, F., Roussel, N., & Oostendorp, R. A. (2012). 
Nociception affects motor output: a review on sensory-motor interaction with focus 
on clinical implications. The Clinical Journal of Pain, 28(2), 175-181.  
Nordlund, M. M., Thorstensson, A., & Cresswell, A. G. (2004). Central and peripheral 
contributions to fatigue in relation to level of activation during repeated maximal 
voluntary isometric plantar flexions. Journal of Applied Physiology, 96(1), 218-225.  
Nosek, T. M., Fender, K. Y., & Godt, R. E. (1987). It is diprotonated inorganic phosphate 
that depresses force in skinned skeletal muscle fibers. Science, 236, 191-194.  
Parmiggiani, F., & Stein, R. (1981). Nonlinear summation of contractions in cat muscles. II. 
Later facilitation and stiffness changes. The Journal of General Physiology, 78(3), 
295-311.  
Pasquet, B., Carpentier, A., Duchateau, J., & Hainaut, K. (2000). Muscle fatigue during 
concentric and eccentric contractions. Muscle & Nerve, 23(11), 1727-1735.  
Pate, E., Bhimani, M., Franks-Skiba, K., & Cooke, R. (1995). Reduced effect of pH on 
skinned rabbit psoas muscle mechanics at high temperatures: implications for fatigue. 
The Journal of Physiology, 486(Pt 3), 689.  
Perrier, J.-F., & Delgado-Lezama, R. (2005). Synaptic release of serotonin induced by 
stimulation of the raphe nucleus promotes plateau potentials in spinal motoneurons of 
the adult turtle. The Journal of Neuroscience, 25(35), 7993-7999.  
Perrier, J.-F., Rasmussen, H. B., Christensen, R. K., & Petersen, A. V. (2013). Modulation of 
the intrinsic properties of motoneurons by serotonin. Current Pharmaceutical Design, 
19(24), 4371-4384.  
73 
 
Petersen, N. T., Pyndt, H. S., & Nielsen, J. B. (2003). Investigating human motor control by 
transcranial magnetic stimulation. Experimental Brain Research, 152(1), 1-16.  
Place, N., Maffiuletti, N. A., Martin, A., & Lepers, R. (2007). Assessment of the reliability of 
central and peripheral fatigue after sustained maximal voluntary contraction of the 
quadriceps muscle. Muscle & Nerve, 35(4), 486-495.  
Powers, R., & Binder, M. (2001). Input-output functions of mammalian motoneurons 
Reviews of Physiology, Biochemistry and Pharmacology (pp. 137-263): Springer. 
Rodriguez-Falces, J., & Place, N. (2014). Effects of muscle fibre shortening on the 
characteristics of surface motor unit potentials. Medical & Biological Engineering & 
Computing, 52(2), 95-107.  
Rodriguez-Falces, J., & Place, N. (2017). Different recoveries of the first and second phases 
of the M-wave after intermittent maximal voluntary contractions. European Journal 
of Applied Physiology, 117(4), 607-618.  
Rodriguez‐Falces, J., & Place, N. (2016). Muscle excitability during sustained maximal 
voluntary contractions by a separate analysis of the M‐wave phases. Scandinavian 
Journal of Medicine & Science in Sports.  
Rösler, K. M. (2001). Transcranial magnetic brain stimulation: a tool to investigate central 
motor pathways. Physiology, 16(6), 297-302.  
Rossi, S., Hallett, M., Rossini, P. M., Pascual-Leone, A., & Group, S. o. T. C. (2009). Safety, 
ethical considerations, and application guidelines for the use of transcranial magnetic 
stimulation in clinical practice and research. Clinical Neurophysiology, 120(12), 
2008-2039.  
Rothwell, J. (1997). Techniques and mechanisms of action of transcranial stimulation of the 
human motor cortex. Journal of Neuroscience Methods, 74(2), 113-122.  
Rothwell, J., Thompson, P., Day, B., Boyd, S., & Marsden, C. (1991). Stimulation of the 
human motor cortex through the scalp. Experimental Physiology, 76(2), 159-200.  
Rozand, V., Cattagni, T., Theurel, J., Martin, A., & Lepers, R. (2015). Neuromuscular 
Fatigue Following Isometric Contractions with Similar Torque Time Integral. 
International Journal of Sports Medicine, 36(1), 35-40.  
Säisänen, L., Pirinen, E., Teitti, S., Könönen, M., Julkunen, P., Määttä, S., & Karhu, J. 
(2008). Factors influencing cortical silent period: optimized stimulus location, 
intensity and muscle contraction. Journal of Neuroscience Methods, 169(1), 231-238.  
Schillings, M. L., Hoefsloot, W., Stegeman, D. F., & Zwarts, M. J. (2003). Relative 
contributions of central and peripheral factors to fatigue during a maximal sustained 
effort. European Journal of Applied Physiology, 90(5-6), 562-568.  
Sidhu, S. K., Bentley, D. J., & Carroll, T. J. (2009). Locomotor exercise induces long-lasting 
impairments in the capacity of the human motor cortex to voluntarily activate knee 
extensor muscles. Journal of Applied Physiology, 106(2), 556-565.  
Sidhu, S. K., Weavil, J. C., Mangum, T. S., Jessop, J. E., Richardson, R. S., Morgan, D. E., & 
Amann, M. (2017). Group III/IV locomotor muscle afferents alter motor cortical and 
corticospinal excitability and promote central fatigue during cycling exercise. Clinical 
Neurophysiology, 128(1), 44-55.  
Snyder, S. H., Katims, J. J., Annau, Z., Bruns, R. F., & Daly, J. W. (1981). Adenosine 
receptors and behavioral actions of methylxanthines. Proceedings of the National 
Academy of Sciences, 78(5), 3260-3264.  
Søgaard, K., Gandevia, S. C., Todd, G., Petersen, N. T., & Taylor, J. L. (2006). The effect of 
sustained low‐intensity contractions on supraspinal fatigue in human elbow flexor 
muscles. The Journal of Physiology, 573(2), 511-523.  
74 
 
Soto, O., Valls-Solé, J., Shanahan, P., & Rothwell, J. (2006). Reduction of intracortical 
inhibition in soleus muscle during postural activity. Journal of Neurophysiology, 
96(4), 1711-1717.  
Stone, M. H., Stone, M. E., & Sands, W. A. (2007). Principles and Practice of Resistance 
Training. Champaign, IL: Human Kinetics. 
Suresh, N. L., Wang, I., Heckman, C., & Rymer, W. Z. (2011). Characterization of the 
tendon vibration reflex response in hemi-spastic stroke individuals. Paper presented at 
the Engineering in Medicine and Biology Society, EMBC, 2011 Annual International 
Conference of the IEEE. 
Tallis, J., James, R. S., Cox, V. M., & Duncan, M. J. (2012). The effect of physiological 
concentrations of caffeine on the power output of maximally and submaximally 
stimulated mouse EDL (fast) and soleus (slow) muscle. Journal of Applied 
Physiology, 112(1), 64-71.  
Taylor, J., & Gandevia, S. (2004). Noninvasive stimulation of the human corticospinal tract. 
Journal of Applied Physiology, 96(4), 1496-1503.  
Taylor, J. L., Allen, G. M., Butler, J. E., & Gandevia, S. (2000). Supraspinal fatigue during 
intermittent maximal voluntary contractions of the human elbow flexors. Journal of 
Applied Physiology, 89(1), 305-313.  
Taylor, J. L., Amann, M., Duchateau, J., Meeusen, R., & Rice, C. L. (2016). Neural 
contributions to muscle fatigue: from the brain to the muscle and back again. 
Medicine and science in sports and exercise, 48(11), 2294.  
Taylor, J. L., Butler, J. E., Allen, G. M., & Gandevia, S. (1996). Changes in motor cortical 
excitability during human muscle fatigue. The Journal of physiology, 490(2), 519-
528.  
Taylor, J. L., Butler, J. E., & Gandevia, S. (2000). Changes in muscle afferents, motoneurons 
and motor drive during muscle fatigue. European Journal of Applied Physiology, 
83(2-3), 106-115.  
Taylor, J. L., & Gandevia, S. C. (2001). Transcranial magnetic stimulation and human muscle 
fatigue. Muscle & nerve, 24(1), 18-29.  
Taylor, J. L., & Gandevia, S. C. (2008). A comparison of central aspects of fatigue in 
submaximal and maximal voluntary contractions. Journal of Applied Physiology, 
104(2), 542-550.  
Trajano, G. S., Seitz, L., Nosaka, K., & Blazevich, A. J. (2013). Contribution of central vs. 
peripheral factors to the force loss induced by passive stretch of the human plantar 
flexors. Journal of Applied Physiology, 115(2), 212-218.  
Trajano, G. S., Seitz, L. B., Nosaka, K., & Blazevich, A. J. (2014). Can passive stretch inhibit 
motoneuron facilitation in the human plantar flexors? Journal of Applied Physiology, 
117(12), 1486-1492.  
Vedsted, P., Larsen, A. H., Madsen, K., & Sjøgaard, G. (2003). Muscle performance 
following fatigue induced by isotonic and quasi‐isometric contractions of rat extensor 
digitorum longus and soleus muscles in vitro. Acta Physiologica Scandinavica, 
178(2), 175-186.  
Vernillo, G., Temesi, J., Martin, M., & Millet, G. Y. (2017). Mechanisms of Fatigue and 
Recovery in Upper versus Lower Limbs in Men. Medicine and science in sports and 
exercise.  
Walton, C., Kalmar, J., & Cafarelli, E. (2003). Caffeine increases spinal excitability in 
humans. Muscle & nerve, 28(3), 359-364.  
Walton, C., Kalmar, J. M., & Cafarelli, E. (2002). Effect of caffeine on self‐sustained firing 
in human motor units. The Journal of physiology, 545(2), 671-679.  
75 
 
Warburton, D. E., Nicol, C. W., & Bredin, S. S. (2006). Health benefits of physical activity: 
the evidence. Canadian medical association journal, 174(6), 801-809.  
Wassermann, E. M. (2002). Variation in the response to transcranial magnetic brain 
stimulation in the general population. Clinical neurophysiology, 113(7), 1165-1171.  
Werhahn, K. J., Kunesch, E., Noachtar, S., Benecke, R., & Classen, J. (1999). Differential 
effects on motorcortical inhibition induced by blockade of GABA uptake in humans. 
The Journal of physiology, 517(2), 591-597.  
Yacyshyn, A. F., Woo, E. J., Price, M. C., & McNeil, C. J. (2016). Motoneuron 
responsiveness to corticospinal tract stimulation during the silent period induced by 
transcranial magnetic stimulation. Experimental brain research, 234(12), 3457-3463.  
Yoon, T., Schlinder Delap, B., Griffith, E. E., & Hunter, S. K. (2007). Mechanisms of fatigue 
differ after low‐and high‐force fatiguing contractions in men and women. Muscle & 
nerve, 36(4), 515-524.  
Yoon, T., Schlinder-Delap, B., Keller, M. L., & Hunter, S. K. (2011). Supraspinal fatigue 
impedes recovery from a low-intensity sustained contraction in old adults. Journal of 
Applied Physiology, 112(5), 849-858.  
 
 
 
76 
 
Appendices 
Appendix 1: Information Letter to Participants (Experiment 1) 
  
Information Letter to Participants 
 
The acute effects of a single strength training session on motor neurone 
excitability and facilitation systems 
 
Thank you for expressing your interest in this research study. The purpose of this 
information letter is to explain the study that you may choose to participate in. Please take a few 
minutes to carefully read the information below, and do not hesitate to ask any questions regarding the 
study methods or equipment or safety concerns. If you agree to participate in the project, you will be 
asked to undertake a screening process to evaluate your suitability for the study. 
 
Project background information 
It is well known that the performance of maximal or near-maximal muscular contractions, 
such as those used during heavy strength training, causes fatigue. Whilst many of the physiological 
changes that underpin fatigue reside in the muscles themselves, at least part of the response resides in 
the central nervous system, which loses its ability to fully activate the muscles. Therefore, 
determining the mechanisms that underpin this loss of neural drive to the muscle is vital in order to 
develop strategies to reduce fatigue and thus improve exercise performance.  
 
Previous research indicates that the transmission of information through the corticospinal 
(brain and spinal cord) tract declines profoundly during fatigue, particularly at the motor neurone, 
(MN; the nerve connecting the spinal cord directly to the muscle). However, the mechanisms 
responsible for the decline remain unclear. Two possible mechanisms have been suggested to 
influence corticospinal transmission efficiency during strength training and other intense exercise 
activities: 1) a decrease in persistent inward current formation; an amplifier for signals at the MN 
which improves the connectivity between the spinal cord and muscle and is needed for us to produce 
large forces but losses its ability to function when we fatigue, and 2) a functional change at the start of 
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the motor neurone (the axon hillock) because of a spillover of serotonin (5-HT), a neurotransmitter 
that often increases nerve function but may reduce it when spillover occurs. 
 
Purpose 
The overall purpose of this research is to: 1) investigate whether a loss in corticospinal 
transmission efficiency contributes to the fatigue that occurs during high-intensity, intermittent, 
voluntary muscular contractions, such as those performed during strength training or other forms of 
high-intensity exercise, and 2) to determine which mechanisms are responsible for the change in 
corticospinal transmission efficiency. This research will be the first of two studies designed to 
understand the effects of corticospinal fatigue in strength training. 
 
Methods 
All testing will be performed at the ECU Exercise Physiology laboratory (19.150) at 
Joondalup. 
 
Participant Requirements 
As a participant you must be between 18-45 years of age with a minimum of 1-year of 
experience in resistance training, no known neurological or cardiovascular diseases, not currently 
taking anti-depressant medication (i.e. serotonin and nor-adrenalin reuptake inhibitors) and consume a 
minimal (<200 mg/day) amount of caffeine (this will be determined by completing a caffeine 
consumption questionnaire). If you decide to participate in the study, you will be asked to report to the 
laboratory on five separate days at the same time of day with at least 72 hours between visits. You 
will be asked to abstain from consuming any foods, beverages or medications containing caffeine for 
at least 12 hours prior to testing sessions. You will also be asked not to consume any depressants (e.g. 
alcohol, medications etc.) for 24 hours prior to testing sessions. Additionally, you will be asked to 
refrain from performing intense exercise 48 hours prior to testing sessions. 
 
What will I be required to do 
In the first visit, you will be familiarised with all of the experimental equipment and 
procedures for the study including; (1) maximal voluntary isometric contractions of the calf muscles 
(MVC), (2) electromyography (EMG; passive recording of the electrical signals from your muscles), 
(3) transcranial magnetic (at the head) electrical stimulations, (4) electrical stimulation of the tibial 
nerve (located on the back of the knee joint), and (5) combined Achilles tendon vibration and tibial 
nerve electrical stimulation. In addition, you will be asked to perform a standardised warm-up 
consisting of 5-minutes of submaximal cycling on a stationary bike followed by five voluntary 
isometric muscle contractions of the calf muscles ranging from 20-100% of perceived maximal effort 
(Familiarisation session). The Familiarisation session will take approximately 60 minutes to 
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complete. The subsequent four visits will be to complete two separate protocols (Protocol A and 
Protocol B) with each protocol containing both a non-caffeine and caffeine ingestion condition to 
assess the potential changes in MN transmission efficiency resulting from fatiguing exercise. 
 
Upon arrival at the laboratory, you will be taken through a preparation period where we will 
position and apply skin-based self-adhesive EMG electrodes on the calf muscles of the right leg to 
record muscle activity. The area underneath the electrodes will be lightly abraded and cleaned with 
alcohol to minimise the risk of infection. After EMG preparation, the correct positioning for electrical 
stimulation of the tibial nerve will be established and the position will be marked with removable ink 
to ensure a consistent position throughout the experimental session. You will then complete the same 
standardised warm-up as in the Familiarisation session. This will take approximately 45-60 minutes.
 
 
Protocol A, Session 1: Transcranial (at the head) Magnetic Stimulation Without Caffeine: 
Protocol A will be performed to determine whether corticospinal (brain and spinal cord) 
excitability/transmission is impaired during fatiguing exercise. During all testing you will be seated 
upright in a chair for testing of knee extension and other force measurements. Magnetic and electrical 
stimulation will occur at the head and at the nerve at the back of the knee respectively. These 
techniques will be performed at various intensities to find the point at which the calf muscle is best 
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recruited. Subsequent testing will then use these intensities to determine your ability to activate the 
muscle during fresh and fatigued states. Once the appropriate intensities are found, you will perform 
six maximal isometric voluntary contractions (MVCs) of the lower leg with overlaid transcranial 
stimuli, followed by three electrical nerve stimuli. 
 
 
 
Exercise protocol 
After a 2-min rest. You will perform 6 sets of 3-second contractions reaching a target level of 
85% of your maximum force with a 90 s rest period between sets. Each set of contractions will be 
stopped when the required force level is not attained on 2 consecutive repetitions, i.e. each set will 
contain a different number of contractions. Transcranial (at the head) stimulation will be performed 
during the 1st, then every third and last contraction of each set. Upon completion of the 6 sets, you 
will perform six maximal voluntary contractions of the lower leg with overlaid transcranial stimuli, 
followed by three electrical nerve stimuli as done before the exercise protocol. You will then repeat 
the six MVCs and three nerve stimuli 10- and 20-minutes after the exercise protocol to determine the 
time it takes for the nervous system to recover. 
 
Protocol A, Session 2: Transcranial Magnetic Stimulation With Caffeine: 
Session 2 is designed to assess the effects of caffeine ingestion on fatigue-induced reductions 
in corticospinal excitability/transmission and force production. You will ingest 3 mg•kg-1 of U.S.P 
grade caffeine supplied in tablet form then wait 1 h to allow the caffeine to be digested. You will then 
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perform the same procedure as done in Session 1 in order to determine whether caffeine reduces the 
neural fatigue that occurs with exercise. 
 
Protocol B, Session 1: Vibration Plus Tibial Nerve Stimulation Without Caffeine: 
Protocol B will be performed to determine whether fatigue in the corticospinal tract is caused 
by a decrease in spinal cord ‘amplification’, or a spillover of the neurotransmitter serotonin. You will 
perform the same standardised warm-up as in the familiarisation, followed by several low-level 
electrical stimuli delivered to the back of the knee at rest, three MVCs of the calf muscles with 
simultaneous electrical stimulation and one tendon vibration plus stimulation technique whereby 
electrical stimulation is applied to the back of the knee in one-second bursts, 5 times, with 1-s 
between each over a constant vibration of the tendon. These tests will be completed immediately 
before and immediately, 5-, 10- and 20-minutes after the fatiguing exercise which will be the same as 
Protocol A (see above).  
 
Protocol B, Session 2: Vibration Plus Tibial Nerve Stimulation With Caffeine: 
In Session 2, the effect of caffeine on fatigue-induced reductions in corticospinal 
excitability/transmission, spinal cord ‘amplification’ and force production will be examined. This 
session will be identical to Session 1 with the exception that you will ingest caffeine 1 h prior to 
testing i.e. you will perform the same warm-up, fatigue and test protocols as in Protocol B, Session 1. 
These sessions will last approximately 2.5 and 3 hours each for the non-caffeine and caffeine trials 
respectively. 
 
Benefits of study participation 
You will have the unique opportunity to learn about and observe advanced 
neurophysiological techniques that probe the activity of the intact human nervous system, particularly 
the central motor pathway controlling muscular force production and human movement. You will also 
have the opportunity to learn about the development of research strategies and research design as well 
as ask questions about research or any aspect of sports science, neuroscience and the role of 
neuroscience in sports science research. Additionally, you will get a free isometric ankle extension 
strength assessment. 
 
Results from your participation will further our understanding of the neuromechanical control 
of muscle force. In addition, your results will aid in the development of interventions that minimise 
the loss of corticospinal excitability during fatiguing exercise and, thus, enhance physical 
performance of patients going through rehabilitation as well as athletes in competition. 
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Potential risks of study participation 
There are some discomforts/risks associated with the procedures being employed in this 
study. Some of the procedures are considered uncomfortable, but they should not be painful. You will 
be asked to perform maximal muscular contractions of the calf muscles so there is a very small risk of 
fainting, exhaustion, cardiac events and musculoskeletal injury, as well as impairment to your ability 
to perform tasks such as driving after the cessation of exercise, however this risk will be minimised 
through the use of a standardised warm-up, test familiarisation and monitoring of physical symptoms 
throughout and the testing session. 
 
Mechanical vibration of the Achilles tendon can cause discomfort, however, it should not be 
painful. During Achilles tendon vibration you may feel like your ankle joint is moving but this is only 
a sensation due to sensory feedback caused by the vibration itself. There is a chance for light bruising 
of the skin underneath the area in contact with the mechanical vibration device. 
 
The use of transcranial magnetic stimulation (TMS) may cause small muscle twitches in the 
scalp, face or arms and also cause small movements of the limbs being targeted (i.e. calf muscles). 
Stimulation of these additional areas is sometimes unavoidable due to the overlapping of the motor 
areas in the brain. On rare occasions TMS may cause muscle tension headaches, which are usually 
mild and easily treated with aspirin. Accidental seizures with someone who has no known history of 
epilepsy and syncope are possible but have not been reported since safety standards were 
implemented in the mid-1990s, and only reported in high-frequency, high-intensity repetitive paired-
pulse stimulation. In the present study we will be delivering single-pulse TMS at moderate intensities 
thus the likelihood of either occurring is low. No side effects have been reported with single-pulse 
TMS and the present study meets the current safety standards for this technique as discussed by Rossi 
et al. (2009) and Rossini et al. (2015). 
 
Electrical stimulation of the peripheral tibial nerve can be uncomfortable, but should not be 
painful. Though highly unlikely, there is a very small risk that you may experience syncope (e.g. 
fainting) from the electrical stimulation. However, because we are using low electrical stimulation 
frequencies and moderate stimulation intensities the risk of syncope is very low. Additionally, the 
light skin abrasion performed prior to application of the skin-based EMG electrodes can increase the 
chance of skin infections. To minimise this risk, alcohol wipes will be applied to the skin after 
abrasion as well as after removal of electrodes. 
 
Caffeine ingestion can cause restlessness, dizziness, anxiety, dehydration, higher body 
temperature, increased breathing and heart rate, and headaches. However, the doses we are using (6 
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mg/kg of bodyweight) are considered physiologically safe and water can be consumed ad libitum 
during testing sessions.  
 
All experimental sessions will be completed under the supervision of a qualified researcher 
(Mr. Benjamin Kirk). We will remind you to tell us immediately if you experience any pain during the 
experimental procedures. If at any stage you are uncomfortable or want to stop the test, you will be 
free to withdraw from this study at any stage without reason or prejudice. 
 
Confidentiality of information  
Information collected will only be available to Mr. Benjamin Kirk and his team of 
researchers. Your personal data will be assigned an identification code, such that only those people 
directly involved in collecting information for the study will be able to recognise which person the 
information pertains to. So that personal information cannot be accessed by those external to the 
study, all personal data will be stored securely by filing data collection sheets (paper versions) on file 
in the School of Medical and Health Sciences and back-up copies on hard disk drive will be 
safeguarded by the research team on password-protected computers. All collected information will be 
retained for a period of 5 years after which the information will be destroyed. 
 
Results of the research study 
The results of this study will be used for the completion of a Masters by Research degree and 
may be presented at conferences/seminars and published in peer-reviewed academic journals, as 
magazine articles, as an online article or part of a book section or report. Additionally, the results of 
this study may be used in future projects. Published results will be summarised as average data for all 
participants and no individual data will be published or presented, meaning your personal information 
cannot be identified unless specific consent for this has been obtained. A copy of published results can 
be obtained from the investigator upon request.  
 
Participant rights 
Your participation in this study is voluntary. No monetary reward will be provided. You 
retain the right to withdraw from the study or refuse single measurements at any time, and no 
justification or explanation is needed if you choose not to participate. There will be no consequences 
for your withdrawal or refusal of single measurements. In addition, if you choose to withdraw from 
the study, you have the right to withdraw any data that has been collected during the research prior to 
publication. If you are a student, your grades/assessments will not be impacted should you decline to 
participate in this study, nor will it affect your relationship with Edith Cowan University. Reporting of 
the study findings will be done with complete confidentiality and your identity will not be disclosed to 
any party outside of the study at any time. You have the right to receive information regarding your 
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own data/results at any time during the study from a member of the research team. You also have the 
right to withdraw any personal information that has been collected during the research. 
 
ECU Human Research Ethics Committee has approved this research project. Should you have 
any questions relating to any of the information provided above, please feel free to contact me or my 
research supervisor, Professor Anthony Blazevich, for further explanation. If you have any concerns 
about this research, or would like to speak to an independent person, you may contact the ECU 
Human Research Ethics Committee. All contact information is below. 
Sincerely,  
Benjamin Kirk, B.Sc. (Hons) 
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Researchers and contact details 
This research project is being undertaken as part of the requirements of a M.Sc. candidature (Exercise 
and Health Sciences) at Edith Cowan University (ECU). 
M.Sc. candidate and Lead Investigator: Mr. Benjamin Kirk 
Supervisor: Professor Anthony Blazevich 
If you have any questions or require any further information regarding the research project, please do 
not hesitate to contact: 
 
M.Sc. Candidate / Lead Researcher   Supervisor 
Mr. Benjamin Kirk     Professor Anthony Blazevich 
Building 19 Room 126     Building 19 Room 3101 
School of Medical and Health Sciences    School of Medical and Health Sciences 
Edith Cowan University     Edith Cowan University 
270 Joondalup Drive     270 Joondalup Drive    
JOONDALUP, WESTERN AUSTRALIA 6027  JOONDALUP, WESTERN AUSTRALIA 
6027 
 
Phone: +61 422 413 142    Phone: (08) 6304 5472  
Email: b.kirk@ecu.edu.au    Email: a.blazevich@ecu.edu.au 
 
Further details of supervisors and the School of Medical and Health Sciences are available at: 
http://www.ecu.edu.au/schools/exercise-and-health-sciences/overview 
 
Independent contact person – Edith Cowan University Research Ethics 
Research Ethics Support Officer 
Human Research Ethics Committee 
Office of Research & Innovation  
Edith Cowan University  
270 Joondalup Drive 
JOONDALUP, WESTERN AUSTRALIA 6027  
Phone: (08) 6304 2170    
Email: research.ethics@ecu.edu.au  
 
The information above should be kept safe so you can refer to it if you need to. 
The following page will be detached and kept by the research team. 
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The acute effects of a single strength training session on motor neurone excitability and 
facilitation systems 
Informed consent form 
Mr. Benjamin Kirk and the research team 
 
Consent for study participation 
 
I [PRINT NAME] ____________________________ confirm that I have read the information 
provided, describing the purpose of the study, methodology (including possible risks) and participant 
rights. I confirm that any questions I have asked have been answered to my satisfaction by the 
investigator. I agree to voluntarily participate in this activity, realizing that I may withdraw at any 
time without reason without prejudice. 
 
I understand that all information provided is treated as strictly confidential and will not be released by 
the investigator unless required to by law. I have been advised as to the purpose of the study, what 
data is being collected and what will be done with the data upon completion of the research. I agree 
that research data obtained for the study may be published (e.g. peer-reviewed publications, 
conferences and text books) provided my name or other identifying information is not used. I 
understand that I can request a copy of this signed form if I wish to retain one for my records. 
 
I request to have my data withdrawn prior to publication if I am excluded or withdraw  
from the project 
 
 
 
 
 
 
__________________________________  
 _________________________ 
        Participant signature                             Date (DD/MM/YYYY)    
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Appendix 2: Pre-exercise Medical Questionnaire 
  
Pre-exercise Medical Questionnaire 
 
The following questionnaire is designed to establish a background of your medical 
history, and identify any injury and/ or illness that may influence your testing and 
performance. 
 
Please answer all questions as accurately as possible, and if you are unsure about 
anything please ask for clarification.  All information provided is strictly confidential.   
 
Personal Details 
 
Name:______________________________________________ 
 
Date of Birth (DD/MM/YYYY):__________________ Gender: Female/ Male 
 
 
PART A 
 
1.  Are you a male over 45 yr, or female over 55 yr or who has had a hysterectomy or 
are postmenopausal?  
    Yes No 
      If YES, please provide details 
 
2.  Are you a regular smoker or have  you Y     N       _______________ 
quit in the last 6 months? 
   
3.  Did a close family member have heart Y     N     Unsure _______________ 
disease or surgery, or stroke before the age  
of 60 years? 
      
4.  Do you have, or have you ever been Y     N     Unsure _______________ 
told you have blood pressure above  
140/90 mmHg, or do you current take  
blood pressure medication?  
 
5.  Do you have, or have you ever been Y     N     Unsure _______________ 
told you have, a total cholesterol level  
above 5.2 mmol/L (200 mg/dL)?  
 
6.  Is your BMI (weight/height2) greater  Y     N     Unsure _______________ 
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than 30 kg/m2?   
 
PART B 
 
1.  Have you ever had a serious asthma  Y N _____________________ 
attack during exercise? 
2.  Do you have asthma that requires  Y N _____________________ 
medication? 
 
3.  Have you had an epileptic seizure in  Y N _____________________ 
the last 5 years? 
 
4.  Do you have any moderate or severe Y N _____________________  
allergies? 
 
5.  Do you, or could you reasonably, have  Y N _____________________ 
an infectious disease? 
 
6.  Do you, or could you reasonably, have  Y N _____________________ 
an infection or disease that might be  
aggravated by exercise? 
 
7.  Do you have any known food, drink Y N _____________________  
and/or medication allergies?    ___________________________ 
      
PART C 
1.  Are you currently taking any prescribed or non-prescribed medications? 
 
      Y N If so please list, 
_____________________________________________________________________ 
_____________________________________________________________________
_____________________________________________________________________ 
 
2.  Have you had, or do you currently have, any of the following? 
 
             If YES, please provide details 
 
Rheumatic fever    Y N _____________________ 
 
Heart abnormalities    Y N _____________________ 
 
Diabetes     Y N _____________________ 
 
Epilepsy     Y N _____________________ 
 
Recurring back pain that would make Y N _____________________ 
exercise problematic, or where exercise  
may aggravate the pain?    
 
Recurring neck pain that would make Y N _____________________ 
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exercise problematic, or where exercise  
may aggravate the pain? 
 
PART C cont’d 
Any neurological disorders that would  Y N _____________________ 
make exercise problematic, or where  
exercise may aggravate the condition? 
 
Any neuromuscular disorders that would  Y N _____________________ 
make exercise problematic, or where  
exercise may aggravate the condition? 
 
Recurring muscle or joint injuries that Y N _____________________ 
would make exercise problematic, or  
where exercise may aggravate the condition?  
 
A burning or cramping sensation in your Y N _____________________ 
legs when walking short distances? 
 
 
Chest discomfort, unreasonable  Y N _____________________ 
breathlessness, dizziness or fainting, 
or blackouts during exercise? 
 
PART D 
Have you had flu in the last week?  Y N _____________________ 
 
Do you currently have an injury that might  Y N _____________________ 
affect, or be affected by, exercise?   
 
Have you ever been told by a medical practitioner or health professional that you have 
a nerve or muscle disorder? 
 
Y N _________________________________________________________ 
 
Do you have any medical implants (e.g. cardiac pacemaker, neurostimulators, etc.)? 
 
Y N _________________________________________________________ 
 
Do you have any metallic implants (e.g. bone pins, neuros)? 
 
Y N _________________________________________________________ 
 
 
*Is there any other condition not previously mentioned that may affect your ability to 
participate in this study? 
 
Y N _________________________________________________________ 
  _________________________________________________________ 
  _________________________________________________________ 
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Please provide information for an emergency contact below: 
Emergency contact name: _____________________       Relation: _______________ 
Home phone number: ___________________       Mobile: _____________________ 
 
Declaration (to be signed in the presence of the researcher) 
 
I acknowledge that the information provided on this form, is to the best of my 
knowledge, a true and accurate indication of my current state of health. 
 
 
Participant 
 
Name:________________________ Date (DD/MM/YYYY):_______________ 
 
Signature:____________________________ 
 
 
Researcher: 
 
Signature:_____________________________ 
  
Date (DD/MM/YYYY):_________________ 
 
 
Practitioner (only if applicable) 
I, Dr _______________________________________ have read the medical 
questionnaire and information/ consent form provided to my patient Mr/Miss/ 
Ms____________________________________, and clear him/ her medically for involvement 
in exercise testing. 
 
Signature:____________________________________ 
 
Date (DD/MM/YYYY):_________________________ 
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Appendix 3: Transcranial Magnetic Stimulation Checklist 
 
TMS Assessment Form and Checklist 
 
Participant Name: _____________________________ 
Date of Birth (DD/MM/YYYY): _________________ 
Phone: _______________________________________ 
 
Please answer ALL questions to the best of your knowledge. ALL INFORMATION FROM 
THIS QUESTIONNAIRE IS STRICTLY CONFIDENTIAL AND IS ONLY USED TO 
SCREEN FOR SAFE PARTICIPATION IN THIS STUDY. Thank you for your 
cooperation. 
 
Does the participant have one or more of the following conditions/implantable devices, which 
could be effected by TMS? 
Positive answers to one or more of questions 1 through 13 may represent contraindications to TMS. 
A risk/benefit ratio will be considered by the Principal Investigator and the participant will be 
required to consult with their GP. 
1) Do you have epilepsy or have you ever had a convulsion or a seizure?        YES       NO 
2) Have you ever had a fainting spell or syncope? If yes, please describe.        YES       NO 
__________________________________________________________ 
__________________________________________________________ 
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3) Have you ever had severe (i.e., followed by loss of consciousness)  
head trauma?           YES      NO 
4) Do you have any hearing problems or ringing in your ears?    YES      NO 
5) Are you pregnant or is there any chance that you might be?    YES       NO 
6) Do you have metal in the brain/skull (except titanium)?  
(e.g. splinters, fragments, clips, etc.)        YES       NO 
7) Do you have cochlear implants?        YES       NO 
8) Do you have an implanted neurostimulator?  
(e.g., DBS, epidural/subdural, VNS)        YES       NO 
9) Do you have a cardiac pacemaker or intracardiac lines or  
metal in your body?          YES       NO 
10) Did you ever have a surgical procedure to your spinal cord?    YES       NO 
11) Do you have spinal ventricular derivations?      YES       NO 
12) Do you have a medication infusion device?      YES       NO 
13) Are you taking ANY medications? (Please list)      YES      NO        
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
____________ 
14) Did you ever undergo TMS in the past?      YES        NO 
15) Did you ever undergo MRI in the past?                           YES        NO 
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Other:______________________________________________________________________ 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
____________ 
The participant can proceed and undergo TMS:                             YES        NO 
Participant signature: ___________________________ 
Date: ___________________________ 
 
Adapted from:  
Rossi et al. (2009). Safety, ethical considerations, and application guidelines for the use 
oftranscranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology, 
10(12): 2008-2039.  
Rossini et al. (2015). Non-invasive electrical and magnetic stimulation of the brain, spinal cord, 
roots and peripheral nerves: basic principles and procedures for routine clinical and research 
application. An updated report from an I.F.C.N. Committee. Clinical Neurophysiology. 
Advance online publication. doi: http://dx.doi.org/10.1016/j.clinph.2015.02.001 
 
 
